<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>Posts | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>Posts</span>
        <span>2024-03-14</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38480549/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">Permanent deterioration of fine motor skills after the resection of tumors in the supplementary motor area</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38480549-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Supplementary motor area syndrome (SMAS) represents a common neurosurgical sequela. The incidence and time frame of its occurrence have yet to be characterized after surgery for brain tumors. We examined patients suffering from a brain tumor preoperatively, postoperatively, and during follow-up examinations after three months, including fine motor skills testing and transcranial magnetic stimulation (TMS). 13 patients suffering from a tumor in the dorsal part of the superior frontal &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38480587/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">The GIST of it all: management of gastrointestinal stromal tumors (GIST) from the first steps to tailored therapy. A bibliometric analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38480587-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Increasing GIST-related publication numbers reflect a continuous progress in the major topic clusters of the GIST research field. Especially in advanced disease stages, questions related to the interplay between surgical approaches and TKI treatment sensitivity should be addressed in future &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38480688/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">NME3 is a gatekeeper for DRP1-dependent mitophagy in hypoxia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38480688-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    NME3 is a member of the nucleoside diphosphate kinase (NDPK) family localized on the mitochondrial outer membrane (MOM). Here, we report a role of NME3 in hypoxia-induced mitophagy dependent on its active site phosphohistidine but not the NDPK function. Mice carrying a knock-in mutation in the Nme3 gene disrupting NME3 active site histidine phosphorylation are vulnerable to ischemia/reperfusion-induced infarction and develop abnormalities in cerebellar function. Our mechanistic analysis &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38480693/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38480693-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38480730/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">Thunder-DDA-PASEF enables high-coverage immunopeptidomics and is boosted by MS&lt;sup&gt;2&lt;/sup&gt;Rescore with MS&lt;sup&gt;2&lt;/sup&gt;PIP timsTOF fragmentation prediction model</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38480730-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Human leukocyte antigen (HLA) class I peptide ligands (HLAIps) are key targets for developing vaccines and immunotherapies against infectious pathogens or cancer cells. Identifying HLAIps is challenging due to their high diversity, low abundance, and patient individuality. Here, we develop a highly sensitive method for identifying HLAIps using liquid chromatography-ion mobility-tandem mass spectrometry (LC-IMS-MS/MS). In addition, we train a timsTOF-specific peak intensity MSÂ²PIP model &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38480824/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">The prevalence of cardiovascular disease risk factors among adults living in extreme poverty</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38480824-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Evidence on cardiovascular disease (CVD) risk factor prevalence among adults living below the World Bank&rsquo;s international line for extreme poverty (those with income &lt;$1.90 per day) globally is sparse. Here we pooled individual-level data from 105 nationally representative household surveys across 78 countries, representing 85% of people living in extreme poverty globally, and sorted individuals by country-specific measures of household income or wealth to identify those in extreme poverty. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38480852/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in Germany</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38480852-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    There are limited data guiding choice of re-induction therapies for patients with relapsed/refractory multiple myeloma (RRMM) prior to stem cell transplantation (SCT). We performed a retrospective medical chart review of 171 patients with RRMM in Germany who received re-induction therapy in second line (78%; n = 134) or third line (22%; n = 37) prior to re-SCT. Index therapy was defined as first completed re-induction therapy for planned myeloablative conditioning and SCT in second/third &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38480884/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">Evolutionary trajectories of small cell lung cancer under therapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38480884-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The evolutionary processes that underlie the marked sensitivity of small cell lung cancer (SCLC) to chemotherapy and rapid relapse are unknown^(1-3). Here we determined tumour phylogenies at diagnosis and throughout chemotherapy and immunotherapy by multiregion sequencing of 160 tumours from 65 patients. Treatment-naive SCLC exhibited clonal homogeneity at distinct tumour sites, whereas first-line platinum-based chemotherapy led to a burst in genomic intratumour heterogeneity and spatial &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38480903/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">MINSTED tracking of single biomolecules</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38480903-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Here we show that MINSTED localization, a method whereby the position of a fluorophore is identified with precisely controlled beams of a STED microscope, tracks fluorophores and hence labeled biomolecules with nanometer/millisecond spatiotemporal precision. By updating the position for each detected photon, MINSTED recognizes fluorophore steps of 16 nm within &lt;250 Î¼s using about 13 photons. The power of MINSTED tracking is demonstrated by resolving the stepping of the motor protein &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38481568/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">Obesity Paradox in Heart Failure with Mildly Reduced Ejection Fraction</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38481568-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: In patients hospitalized with HFmrEF, lower BMI was associated with increased risk of all-cause mortality at 30 months, suggesting an obesity paradox in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38481868/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">Clinical management, differential diagnosis, follow-up and biomarkers of infertile men with nonobstructive azoospermia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38481868-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38482688/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">Uncertain Facts or Uncertain Values? Testing the Distinction Between Empirical and Normative Uncertainty in Moral Judgments</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38482688-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    People can be uncertain in their moral judgments. Philosophers have argued that such uncertainty can either refer to the underlying empirical facts (empirical uncertainty) or to the normative evaluation of these facts itself (normative uncertainty). Psychological investigations of this distinction, however, are rare. In this paper, we combined factor-analytical and experimental approaches to show that empirical and normative uncertainty describe two related but different psychological states. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38483091/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">Synthesis and structural properties of &lt;em&gt;para&lt;/em&gt;-diselenopyrazines</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38483091-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Recently, dithienopyrazines have emerged as promising building blocks in the field of materials science, showcasing their potential as hole-transport materials in organic electronic devices. Herein, we report the synthesis of its heavier analogues, the diselenopyrazines, along with an analysis of their optoelectronic and structural properties. In the acquired crystal structures, interesting molecular packing motifs suitable for potential device fabrication were observed. Additionally, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38483100/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">Factors influencing migration of short-finned eels (Anguilla australis) over 3â€‰years from a wetland system, Lake Condah, south-east Australia, downstream to the sea</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38483100-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Anguillid eel populations are under threat globally. A particularly vulnerable life-cycle stage is the migration of mature adult eels downstream from freshwater habitats through estuaries into the sea to spawn. This study investigated the factors associated with downstream migration of the short-finned eel Anguilla australis (Richardson 1841) from a coastal wetland (Lake Condah) in south-east Australia, using acoustic telemetry. Migration was associated with time of the year, higher water &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38483117/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">The rapid growth of bibliometric studies: a call for international guidelines (Correspondence)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38483117-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38483155/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240314180531&amp;v=2.18.0.post9&#43;e462414">Second Primary Malignancies After Commercial CAR T Cell Therapy: Analysis of FDA Adverse Events Reporting System (FAERS)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38483155-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240314180531-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Second primary malignancies (SPMs) were reported in 536 out of 12,394 (4.3%) adverse event reports following CAR T cell therapies in the FDA Adverse Event Reporting System (FAERS). Myeloid and T-cell neoplasms were disproportionately more frequently reported, warranting further &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38483241/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">Dermatoscopic patterns of cutaneous metastases: A multicentre cross-sectional study of the International Dermoscopy Society</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38483241-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The head and neck area is a common site for distant CMs. Our study confirms that most pigmented melanoma metastasis are structureless blue on dermatoscopy and may mimic blue nevi. Amelanotic metastases are typified by linear serpentine vessels and a white structureless pattern, regardless of the primary &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38483405/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240314180531&amp;v=2.18.0.post9&#43;e462414">Monomorphic epitheliotropic T-cell lymphoma with strong CD4 expression</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38483405-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240314180531-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38483406/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240314180531&amp;v=2.18.0.post9&#43;e462414">Aging Kairos: treating older Hodgkin patients</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38483406-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240314180531-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38483407/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240314180531&amp;v=2.18.0.post9&#43;e462414">Hemolysis impairs sickle cell erythropoiesis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38483407-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240314180531-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38483408/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240314180531&amp;v=2.18.0.post9&#43;e462414">It&#39;s all about complement balance, again</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38483408-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240314180531-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38483409/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240314180531&amp;v=2.18.0.post9&#43;e462414">Systemic mastocytosis: dying or survivin</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38483409-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240314180531-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38483410/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240314180531&amp;v=2.18.0.post9&#43;e462414">A road map of relapse in MDS after allo-HSCT</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38483410-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240314180531-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O4VNcn1KA">ä»Šå¤©ä¸Šçº¿çš„NEJMæœ€é‡è¦æ–‡ç« æ˜¯å¤–å‘¨è¡€cfDNAç”¨ä½œç»“ç›´è‚ ç™Œå‰ç—…å˜å’Œç»“ç›´è‚ ç™Œè¯Šæ–­æ ‡è®°ç‰©çš„ç ”ç©¶ï¼Œè¿™ä¸ªç ”ç©¶å¯¹ä»Šåçš„ç»“ç›´è‚ ç™Œé¢„é˜²å’Œè¯„ä¼°æ²»ç–—æ•ˆæœå…·æœ‰ååˆ†é‡å¤§æ„ä¹‰ï¼Œå› æ­¤ä¹Ÿ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o4vncn1ka/">
    
    
    
    
    
      
    
    ä»Šå¤©ä¸Šçº¿çš„NEJMæœ€é‡è¦æ–‡ç« æ˜¯å¤–å‘¨è¡€cfDNAç”¨ä½œç»“ç›´è‚ ç™Œå‰ç—…å˜å’Œç»“ç›´è‚ ç™Œè¯Šæ–­æ ‡è®°ç‰©çš„ç ”ç©¶ï¼Œè¿™ä¸ªç ”ç©¶å¯¹ä»Šåçš„ç»“ç›´è‚ ç™Œé¢„é˜²å’Œè¯„ä¼°æ²»ç–—æ•ˆæœå…·æœ‰ååˆ†é‡å¤§æ„ä¹‰ï¼Œå› æ­¤ä¹Ÿå¾—åˆ°äº†å¾ˆå¤šåª’ä½“å…³æ³¨ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->åœ¨è¿‡å»å‡ åå¹´å› ä¸ºé¥®é£Ÿä¹ æƒ¯æ”¹å˜ï¼Œç»“ç›´è‚ ç™Œæˆä¸ºäº†å…¨äººç±»é¢ä¸´çš„ä¸€ä¸ªå·¨å¤§å¥åº·å¨èƒã€‚æ—©æœŸç»“ç›´è‚ ç™Œæ˜¯å¯ä»¥è¢«å½»åº•æ²»æ„ˆçš„ï¼Œå› æ­¤å‘ç°ç»“ç›´è‚ ç™Œå‰ç—…å˜å’Œæ—©æœŸè‚¿ç˜¤éå¸¸å…³é”®ï¼›ç„¶è€Œï¼Œå‘ç°æ—©æœŸç»“ç›´è‚ ç™Œéå¸¸å›°éš¾ï¼Œè¿™æ˜¯å› ä¸ºç»“ç›´è‚ ç™Œç¼ºå°‘ç®€å•æ˜“è¡Œä¸”çµæ•åº¦å’Œç‰¹å¼‚æ€§é«˜çš„è‚¿ç˜¤æ ‡è®°ç‰©ï¼ˆbiomarkerï¼‰ï¼Œå› æ­¤è‚ é•œä¾ç„¶æ˜¯æœ€ä¸»è¦çš„ä½“æ£€ã€ç­›æŸ¥å’Œè¯Šæ–­ç»“ç›´è‚ ç™Œæ–¹æ³•ã€‚åœ¨ç¾å›½ï¼ŒåŒ»ç–—ä¿é™©ä¼šæ‰¿æ‹…50å²ä»¥ä¸Šä¸­è€å¹´äººæ¯åå¹´ä¸€æ¬¡çš„è‚ é•œæ£€æŸ¥ï¼Œä½†å…¶æ™®åŠæ€§éå¸¸ä¸å¥½ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->è¿™é¡¹MGHé¢†è¡”çš„å…¨çƒå¤šä¸´åºŠä¸­å¿ƒçš„ECLIPSEé˜Ÿåˆ—ç ”ç©¶ï¼ˆNCT04136002ï¼‰å…¥ç»„äº†7861åæ‚£è€…ï¼Œå‘ç°83.1%çš„è‚ é•œè¯Šæ–­æœ‰ç»“ç›´è‚ ç™Œçš„æ‚£è€…è¡€æµ†cfDNAï¼ˆcell free DNAï¼‰é˜³æ€§ï¼Œ16.9%é˜´æ€§ï¼Œè¿™æç¤ºè¡€æµ†cfD &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O4Xjh6cxK">ä¸€ç‚¹å…³äºè‚¿ç˜¤çš„æ€è€ƒï¼Œä½†è¿™å…¶å®æ˜¯ä¸€äº›è‚¿ç˜¤å­¦å’Œç—…ç†å­¦çš„å¸¸è¯†ã€‚å¦‚æœä»ç»„ç»‡æ¥æºã€ç—…ç†ç±»å‹å’Œç—…å› /è¯±å› è§’åº¦å»æ€è€ƒä¸€äº›ä¸­å›½äººé«˜å‘çš„å®ä½“è‚¿ç˜¤ï¼Œå…¶å®æ˜¯å¾ˆæœ‰è§„å¾‹çš„ã€‚æ¶ˆåŒ–...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o4xjh6cxk/">
    
    
    
    
    
      
    
    ä¸€ç‚¹å…³äºè‚¿ç˜¤çš„æ€è€ƒï¼Œä½†è¿™å…¶å®æ˜¯ä¸€äº›è‚¿ç˜¤å­¦å’Œç—…ç†å­¦çš„å¸¸è¯†ã€‚å¦‚æœä»ç»„ç»‡æ¥æºã€ç—…ç†ç±»å‹å’Œç—…å› /è¯±å› è§’åº¦å»æ€è€ƒä¸€äº›ä¸­å›½äººé«˜å‘çš„å®ä½“è‚¿ç˜¤ï¼Œå…¶å®æ˜¯å¾ˆæœ‰è§„å¾‹çš„ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->æ¶ˆåŒ–é“å’Œç”Ÿæ®–é“çš„è‚¿ç˜¤ï¼Œå‘ç”Ÿåœ¨è¿œç«¯çš„ï¼ˆå‡ºå£/å…¥å£å¦‚å£è…”ã€å’½å–‰ã€é£Ÿç®¡ã€è‚›ç®¡ã€å¤–é˜´ç­‰éƒ¨ä½ï¼‰ï¼Œé€šå¸¸æ˜¯é³ç™Œï¼Œè¿™æ˜¯å› ä¸ºè¿™äº›éƒ¨ä½çš„è¢«è¦†ä¸Šçš®æ˜¯æ‰å¹³ä¸Šçš®ï¼Œä¹Ÿå°±æ˜¯é³çŠ¶ä¸Šçš®ï¼ˆæ¥æºäºå†…å¤–èƒšå±‚ï¼‰ï¼Œä»¥æ‰¿å—å‹åŠ›å¹¶èµ·ç¼“å†²å’Œä¿æŠ¤ä½œç”¨ã€‚è¿™äº›éƒ¨ä½æ¯”å¦‚å£è…”ã€è‚›ç®¡ã€å¤–é˜´éå¸¸å®¹æ˜“è¢«HPVæ„ŸæŸ“ï¼Œè€ŒHPVå­˜ç•™åœ¨ä¸å®¹æ˜“è¢«å…ç–«ç³»ç»Ÿæ¸…é™¤çš„è¢«è¦†ä¸Šçš®ç»„ç»‡çš„åŸºåº•å±‚ï¼ŒHPVè‡´ç™ŒåŸºå› E1/2/6/7ä¼šä½¿åŸºåº•å±‚ç»†èƒå‘ç”Ÿå¢ç”Ÿï¼Œéå…¸å‹å¢ç”Ÿåˆ™å¯èƒ½ä¼šå¯¼è‡´è‚¿ç˜¤å‘ç”Ÿã€‚åŒæ ·æ˜¯ç—…æ¯’æ„ŸæŸ“ï¼Œæ¶ˆåŒ–ç³»ç»Ÿæœ€å¤§çš„æ¶ˆåŒ–è…º - &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O52sY62IK">ä»Šå¤©NYT The Dailyéå¸¸å¥½ï¼Œè¿™æœŸèŠ‚ç›®è¯·äº†NYTä¸“é—¨æŠ¥é“ç¾è”å‚¨ï¼ˆFederal Reserveï¼‰çš„ç»æµè®°è€…Jeanna Smialekè®²äº†ç¾å›½ä¸€ä¸ªç‰¹æ®Šäººå£ç»æµç°è±¡ï¼Œæ°å¥½å‘¨ä¸€çš„538ä¹Ÿè°ˆåˆ°äº†åŒ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o52sy62ik/">
    
    
    
    
    
      
    
    ä»Šå¤©NYT The Dailyéå¸¸å¥½ï¼Œè¿™æœŸèŠ‚ç›®è¯·äº†NYTä¸“é—¨æŠ¥é“ç¾è”å‚¨ï¼ˆFederal Reserveï¼‰çš„ç»æµè®°è€…Jeanna Smialekè®²äº†ç¾å›½ä¸€ä¸ªç‰¹æ®Šäººå£ç»æµç°è±¡ï¼Œæ°å¥½å‘¨ä¸€çš„538ä¹Ÿè°ˆåˆ°äº†åŒæ ·çš„ç°è±¡ï¼Œå°±æ˜¯2009å¹´é«˜ä¸­æ¯•ä¸šçš„1990-1991å¹´å‡ºç”Ÿçš„äººå£æ˜¯ç›®å‰ç¾å›½æŒ‰å¹´é¾„æ®µåˆ†å¸ƒçš„ç¬¬ä¸€å¤§äººå£ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->ç¾å›½äººå£æŒ‰å¹´ä»£åˆ†ç±»ï¼Œä¸»è¦è¢«åˆ†ä¸º4ç±»ï¼šäºŒæˆ˜ååˆ°1964å¹´å‡ºç”Ÿçš„Boomersï¼Œ1965-1980å¹´å‡ºç”Ÿçš„Gen Xï¼Œ1981-1994å¹´å‡ºç”Ÿçš„Millennialsï¼ˆGen Yï¼‰ï¼Œ1995-2009å¹´å‡ºç”Ÿçš„Gen Zã€‚ç›®å‰ç¾å›½äººå£ä¸­ï¼ŒMillennialsæ˜¯ç¬¬ä¸€å¤§äººå£ï¼Œè€ŒMillennialsä¸­çš„2009å¹´é«˜ä¸­æ¯•ä¸šçš„1990-1991å¹´é¾„æ®µç¾å›½æ‰€æœ‰å¹´é¾„ä¸­çš„ç¬¬ä¸€å¤§äººå£å¹´é¾„ã€‚æŒ‰é«˜ä¸­æ¯•ä¸šçš„å¹´æ•°æ¥è®¡ç®—ï¼Œç¾å›½å¹³å‡æ¯å¹´æœ‰4-5ç™¾ä¸‡äººï¼Œä½†20 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O51BEoCxZ">ğŸ”»ã€Šä¸–ç•ŒæŠ¥ã€‹å†™é“ï¼Œ2æœˆ21æ—¥ï¼Œé©¬å…‹é¾™è¡¨ç¤ºæ³•å›½å†›é˜Ÿâ€œåœ¨æœªæ¥ä¸€å¹´å†…å¯èƒ½å°†ä¸å¾—ä¸é©»æ‰åœ¨æ•–å¾·è¨â€ã€‚3æœˆ6æ—¥ï¼Œé©¬å…‹é¾™åœ¨ä¸å„å…šä¼šè°ˆçš„æ—¶å€™è¡¨ç¤ºï¼Œâ€œå¦‚æœæˆ˜çº¿å‘åŸºè¾…æˆ–æ•–å¾·...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o51beocxz/">
    
    
    
    
    
      
    
    ğŸ”»ã€Šä¸–ç•ŒæŠ¥ã€‹å†™é“ï¼Œ2æœˆ21æ—¥ï¼Œé©¬å…‹é¾™è¡¨ç¤ºæ³•å›½å†›é˜Ÿâ€œåœ¨æœªæ¥ä¸€å¹´å†…å¯èƒ½å°†ä¸å¾—ä¸é©»æ‰åœ¨æ•–å¾·è¨â€ã€‚3æœˆ6æ—¥ï¼Œé©¬å…‹é¾™åœ¨ä¸å„å…šä¼šè°ˆçš„æ—¶å€™è¡¨ç¤ºï¼Œâ€œå¦‚æœæˆ˜çº¿å‘åŸºè¾…æˆ–æ•–å¾·è¨æ¨è¿›ï¼Œæ³•å›½å¯èƒ½ä¼šå‘ä¹Œå…‹å…°æ´¾é£å†›é˜Ÿâ€ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O51orCemP">ğŸ”»ğŸ‡©ğŸ‡ªæ˜é•œï¼šå¾·å›½è”é‚¦è®®é™¢ç¬¬ä¸‰æ¬¡æ‹’ç»å‘ä¹Œå…‹å…°æä¾›é‡‘ç‰›åº§å·¡èˆªå¯¼å¼¹ã€‚ğŸ”»188ç¥¨æ”¯æŒï¼Œ494ç¥¨åå¯¹ï¼Œ5ç¥¨å¼ƒæƒã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o51orcemp/">
    
    
    
    
    
      
    
    ğŸ”»ğŸ‡©ğŸ‡ªæ˜é•œï¼šå¾·å›½è”é‚¦è®®é™¢ç¬¬ä¸‰æ¬¡æ‹’ç»å‘ä¹Œå…‹å…°æä¾›é‡‘ç‰›åº§å·¡èˆªå¯¼å¼¹ã€‚<!-- raw HTML omitted -->ğŸ”»188ç¥¨æ”¯æŒï¼Œ494ç¥¨åå¯¹ï¼Œ5ç¥¨å¼ƒæƒã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O51rH7MTJ">ğŸ”»ç»™å¤§å®¶è®²ä¸ªç¬‘è¯ï¼Œç¾å›½ CSIS åœ¨å…µ æ¨ä¸­å®£ç§°ï¼šç¾å†›æ½œè‰‡å°†è¿›å…¥å° æ¹¾ æµ· å³¡å†…æ´»åŠ¨ã€‚ğŸ”»ç®€å•ç§‘æ™®ä¸€ä¸‹æµ· å³¡æ°´æ·±ï¼š30-50ç±³ã€‚ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o51rh7mtj/">
    
    
    
    
    
      
    
    ğŸ”»ç»™å¤§å®¶è®²ä¸ªç¬‘è¯ï¼Œç¾å›½ CSIS åœ¨å…µ æ¨ä¸­å®£ç§°ï¼šç¾å†›æ½œè‰‡å°†è¿›å…¥å° æ¹¾ æµ· å³¡å†…æ´»åŠ¨ã€‚<!-- raw HTML omitted -->ğŸ”»ç®€å•ç§‘æ™®ä¸€ä¸‹æµ· å³¡æ°´æ·±ï¼š30-50ç±³ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O51UJh44K">ğŸ”»ä¹Œå‹ï¼šâ€œä¿„ç½—æ–¯çš„åˆ«å°”å“¥ç½—å¾·ç°åœ¨çœ‹èµ·æ¥å°±åƒä¹Œå…‹å…°çš„å‰çº¿åŸå¸‚ï¼šå‡ è¾†è½¦è¾†ï¼ŒåŒ…æ‹¬ä¸€è¾†çœ‹èµ·æ¥åƒæ•‘æŠ¤è½¦çš„è½¦è¾†ï¼Œåœ¨é“è·¯ä¸Šè¢«æ’å¹¶èµ·ç«ã€‚â€ğŸ”»ç½‘å‹ï¼šâ€œè¿™æ˜¯ 2022 å¹´ 1...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o51ujh44k/">
    
    
    
    
    
      
    
    ğŸ”»ä¹Œå‹ï¼šâ€œä¿„ç½—æ–¯çš„åˆ«å°”å“¥ç½—å¾·ç°åœ¨çœ‹èµ·æ¥å°±åƒä¹Œå…‹å…°çš„å‰çº¿åŸå¸‚ï¼šå‡ è¾†è½¦è¾†ï¼ŒåŒ…æ‹¬ä¸€è¾†çœ‹èµ·æ¥åƒæ•‘æŠ¤è½¦çš„è½¦è¾†ï¼Œåœ¨é“è·¯ä¸Šè¢«æ’å¹¶èµ·ç«ã€‚â€<!-- raw HTML omitted -->ğŸ”»ç½‘å‹ï¼šâ€œè¿™æ˜¯ 2022 å¹´ 1 æœˆï¼Œå“ˆè¨å…‹æ–¯å¦é˜¿æ‹‰æœ¨å›¾ï¼Œå°ä¸‘ã€‚â€<!-- raw HTML omitted -->ğŸ”»æºï¼šX <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O51wygjiG">ğŸ”»å®ƒå€¼å¾—ã€‚ğŸ”»æºï¼šdian.11.11 [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o51wygjig/">
    
    
    
    
    
      
    
    ğŸ”»å®ƒå€¼å¾—ã€‚<!-- raw HTML omitted -->ğŸ”»æºï¼šdian.11.11 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O51YhfBwi">ğŸ”»ç¦å²›ã€‚ğŸ”»æ™šå®‰ã€‚ğŸ”»æºï¼šNHK</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o51yhfbwi/">
    
    
    
    
    
      
    
    ğŸ”»ç¦å²›ã€‚<!-- raw HTML omitted -->ğŸ”»æ™šå®‰ã€‚<!-- raw HTML omitted -->ğŸ”»æºï¼šNHK <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/jF4loiGdlx08dhXabpu8010412003ulO0E010.mp4?label=mp4_ld&amp;amp;template=640x360.25.0&amp;amp;ori=0&amp;amp;ps=1CwnkDw1GXwCQx&amp;">https://f.video.weibocdn.com/o0/jF4loiGdlx08dhXabpu8010412003ulO0E010.mp4?label=mp4_ld&amp;amp;template=640x360.25.0&amp;amp;ori=0&amp;amp;ps=1CwnkDw1GXwCQx&amp;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O52Flsl5z">ğŸ”»åœ¨ä»¥è‰²åˆ—åŠ ç‰¹é•‡ä»¥å—çš„æ‹œç‰¹å¡é©¬ï¼Œå·´å‹’æ–¯å¦äººå°è¯•ç”¨å‘½æ¥å…‘æ‰ä»¥è‰²åˆ—å†›å®˜ã€‚ğŸ”»ä»¥è‰²åˆ—åª’ä½“ ×—×“×©×•×ª ××”×©×˜×— ×‘×˜×œ×’×¨× ç§°ï¼Œä¸€ä¸ªå¤šæ˜ŸæœŸä»¥å‰ï¼Œä»–åœ¨ä»¥è‰²åˆ—...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o52flsl5z/">
    
    
    
    
    
      
    
    ğŸ”»åœ¨ä»¥è‰²åˆ—åŠ ç‰¹é•‡ä»¥å—çš„æ‹œç‰¹å¡é©¬ï¼Œå·´å‹’æ–¯å¦äººå°è¯•ç”¨å‘½æ¥å…‘æ‰ä»¥è‰²åˆ—å†›å®˜ã€‚<!-- raw HTML omitted -->ğŸ”»ä»¥è‰²åˆ—åª’ä½“ ×—×“×©×•×ª ××”×©×˜×— ×‘×˜×œ×’×¨× ç§°ï¼Œä¸€ä¸ªå¤šæ˜ŸæœŸä»¥å‰ï¼Œä»–åœ¨ä»¥è‰²åˆ—å¯¹åŠ æ²™çš„ç©ºè¢­ä¸­å¤±å»äº†çˆ¶äº²ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com">https://f.video.weibocdn.com</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O52pCsFuh">ğŸ”»BBCï¼šå—éã€å°¼æ—¥åˆ©äºšã€åŠ çº³ã€åˆ©æ¯”é‡Œäºšã€ç§‘ç‰¹è¿ªç“¦å’Œå¸ƒåŸºçº³æ³•ç´¢ç­‰å›½å®¶å‡ºç°äº†ä¸¥é‡æ–­ç½‘ã€‚ğŸ”»ç°åœ¨ã€‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o52pcsfuh/">
    
    
    
    
    
      
    
    ğŸ”»BBCï¼šå—éã€å°¼æ—¥åˆ©äºšã€åŠ çº³ã€åˆ©æ¯”é‡Œäºšã€ç§‘ç‰¹è¿ªç“¦å’Œå¸ƒåŸºçº³æ³•ç´¢ç­‰å›½å®¶å‡ºç°äº†ä¸¥é‡æ–­ç½‘ã€‚<!-- raw HTML omitted -->ğŸ”»ç°åœ¨ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O537JgBdw">ğŸ”»ä¹Ÿé—¨é¢†è¢–é˜¿åœæœå‹’-é©¬åˆ©å…‹Â·å·´å¾·å°”Â·ä¸Â·èƒ¡å¡å‘è¡¨è®²è¯ã€‚ğŸ”»é‡ç‚¹ï¼šæˆ˜æ–—è‡³ä»Šï¼Œä¹Ÿé—¨æ­¦è£…éƒ¨é˜Ÿä¸€å…±ç‰º ç‰²34äººã€‚ä¹Ÿé—¨å°†æ¨åŠ¨å°é”å±€åŠ¿å‡çº§ï¼Œåœ¨å°åº¦æ´‹è¿½å‡»ä»¥è‰²åˆ—èˆ¹åªå¹¶...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o537jgbdw/">
    
    
    
    
    
      
    
    ğŸ”»ä¹Ÿé—¨é¢†è¢–é˜¿åœæœå‹’-é©¬åˆ©å…‹Â·å·´å¾·å°”Â·ä¸Â·èƒ¡å¡å‘è¡¨è®²è¯ã€‚<!-- raw HTML omitted -->ğŸ”»é‡ç‚¹ï¼šæˆ˜æ–—è‡³ä»Šï¼Œä¹Ÿé—¨æ­¦è£…éƒ¨é˜Ÿä¸€å…±ç‰º ç‰²34äººã€‚ä¹Ÿé—¨å°†æ¨åŠ¨å°é”å±€åŠ¿å‡çº§ï¼Œåœ¨å°åº¦æ´‹è¿½å‡»ä»¥è‰²åˆ—èˆ¹åªå¹¶é˜»æ­¢å…¶é©¶å‘å¥½æœ›è§’ï¼Œä»»ä½•ä¸ä»¥è‰²åˆ—æœ‰è”ç³»çš„èˆ¹åªéƒ½å®¹æ˜“å—åˆ°ä¹Ÿé—¨å¯¼å¼¹çš„æ”»å‡»ã€‚<!-- raw HTML omitted -->ğŸ”»æºï¼šmmy.ye <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/6">https://tvax1.sinaimg.cn/large/6</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O539BgxOc">å‘µ æŸ¥çœ‹å›¾ç‰‡ //@æœ‰æ’å¿ƒæ‰æœ‰æ’äº§:è¿™éƒ½å¹²ä¸æ­»ï¼Œæ²¡åƒé¥±å— - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»åœ¨ä»¥è‰²åˆ—åŠ ç‰¹é•‡ä»¥å—çš„æ‹œç‰¹å¡é©¬ï¼Œå·´å‹’æ–¯å¦äººå°è¯•ç”¨å‘½æ¥å…‘æ‰ä»¥è‰²åˆ—å†›å®˜ã€‚...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o539bgxoc/">
    
    
    
    
    
      
    
    å‘µ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¥çœ‹å›¾ç‰‡<!-- raw HTML omitted --><!-- raw HTML omitted --> //<!-- raw HTML omitted -->@æœ‰æ’å¿ƒæ‰æœ‰æ’äº§<!-- raw HTML omitted -->:è¿™éƒ½å¹²ä¸æ­»ï¼Œæ²¡åƒé¥±å—<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»åœ¨ä»¥è‰²åˆ—åŠ ç‰¹é•‡ä»¥ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O4WNXemKn">å›´æ£‹è®°è€…è¿˜æ˜¯å¾…é‡å¤ªå·®äº†ï¼Œä¸ç„¶ç©·é…¸æ„Ÿå®åœ¨å†™ä¸åˆ°å¦‚æ­¤å…¥æœ¨ä¸‰åˆ†[good] - è½¬å‘ @å¼ˆå®¢å›´æ£‹:&amp;ensp;å‘å¸ƒäº†æ–‡ç«  ã€Šç»ˆäºæœ‰æˆ¿äº†ï¼ç”³çœŸè°åœ¨é¦–å°”è´­æˆ¿ ç»“æŸ12å¹´ç§Ÿæˆ¿ç”Ÿæ´»ã€‹ ç»ˆ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o4wnxemkn/">
    
    
    
    
    
      
    
    å›´æ£‹è®°è€…è¿˜æ˜¯å¾…é‡å¤ªå·®äº†ï¼Œä¸ç„¶ç©·é…¸æ„Ÿå®åœ¨å†™ä¸åˆ°å¦‚æ­¤å…¥æœ¨ä¸‰åˆ†<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å¼ˆå®¢å›´æ£‹<!-- raw HTML omitted -->:â€‚å‘å¸ƒäº†æ–‡ç«  ã€Šç»ˆäºæœ‰æˆ¿äº†ï¼ç”³çœŸè°åœ¨é¦–å°”è´­æˆ¿ ç»“æŸ12å¹´ç§Ÿæˆ¿ç”Ÿæ´»ã€‹ <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_a">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_a</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O50TLrPNr">//@é¡¶ç­†TENä½¿:ä¹…ä¿å²ç»ªé‡Œ[å…¨åŠ›ä»¥èµ´] - è½¬å‘ @ä¹ƒæœ¨å‚46:&amp;ensp;ğŸ“¸#ä¹ƒæœ¨å‚46GALLERY#ğŸ“¸[æŠ±ä¸€æŠ±]#3æœŸç”Ÿ# Works[æŠ±ä¸€æŠ±]ä¹ƒæœ¨å‚46 #ä¹…ä¿å²ç»ªé‡Œ# #é˜ªå£ç ç¾# #ä½è—¤...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o50tlrpnr/">
    
    
    
    
    
      
    
    //<!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[å…¨åŠ›ä»¥èµ´]&quot; src=&ldquo;<a href="https://face.t.sinajs.cn/t4/appstyle/expression/ext/normal/d9/2023_fighting_org.png%22">https://face.t.sinajs.cn/t4/appstyle/expression/ext/normal/d9/2023_fighting_org.png&quot;</a>  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O50TOsroC">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.ç»ªè¡Œè®° fb [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o50tosroc/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ç»ªè¡Œè®° fb &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1hnqowmtmpuj30u00u0mzh.jpg%22">https://tvax1.sinaimg.cn/large/006z6nxLgy1hnqowmtmpuj30u00u0mzh.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O51GVCR1z">çœŸæ˜¯å¾…ä¸ä¸‹å»äº†</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o51gvcr1z/">
    
    
    
    
    
      
    
    çœŸæ˜¯å¾…ä¸ä¸‹å»äº†  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O51J8l6Ca">å¦‚æœä½ ä»¬èŠä¹ƒæœ¨å‚å…¨æ˜¯è´Ÿé¢çš„è¾“å‡ºçš„è¯é‚£ä½ ä»¬è¿˜æ˜¯èŠæ¨±å‚å§</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o51j8l6ca/">
    
    
    
    
    
      
    
    å¦‚æœä½ ä»¬èŠä¹ƒæœ¨å‚å…¨æ˜¯è´Ÿé¢çš„è¾“å‡ºçš„è¯<!-- raw HTML omitted -->é‚£ä½ ä»¬è¿˜æ˜¯èŠæ¨±å‚å§  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O51LowzB4">æœ¬æ¥æƒ³åƒä¸ªçƒ­å¹²é¢ç»“æœå®Œå…¨æ²¡å¿ƒæƒ…äº†</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o51lowzb4/">
    
    
    
    
    
      
    
    æœ¬æ¥æƒ³åƒä¸ªçƒ­å¹²é¢ç»“æœå®Œå…¨æ²¡å¿ƒæƒ…äº†  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O51MfivRV">æ¼ç¾æˆæ€’å°±æ˜¯è¿™ç§æ„Ÿè§‰å§</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o51mfivrv/">
    
    
    
    
    
      
    
    æ¼ç¾æˆæ€’å°±æ˜¯è¿™ç§æ„Ÿè§‰å§  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O51VD3Coj">å¥½å˜Ÿ - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ3æœˆ15æ—¥ 18:00ã€œ18:30 (æ—¥æœ¬æ—¶é—´) SHOWROOMã€Œã®ããŠã³ã€ä¹…ä¿å²ç·’é‡Œ æ¾å°¾ç•™çš„ä½œä¸šæ˜¯ï¼šæœ‰ä»€ä¹ˆè¿˜æ²¡è¡¨æ¼”è¿‡çš„æƒ³è¦è¯•è¯•çœ‹çš„äº‹...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o51vd3coj/">
    
    
    
    
    
      
    
    å¥½å˜Ÿ<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->3æœˆ15æ—¥ 18:00ã€œ18:30 (æ—¥æœ¬æ—¶é—´) SHOWROOMã€Œã®ããŠã³ã€ä¹…ä¿å²ç·’é‡Œ <!-- raw HTML omitted -->æ¾å°¾ç•™çš„ä½œä¸šæ˜¯ï¼šæœ‰ä»€ä¹ˆè¿˜æ²¡è¡¨æ¼”è¿‡çš„æƒ³è¦è¯•è¯•çœ‹çš„äº‹å—ï¼Ÿæˆ‘çš„è¯ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O51Vuhak4">æƒ³äº†æƒ³è¿˜æ˜¯æˆ‘çš„é—®é¢˜ï¼Œæ˜æ˜æ˜¯æƒ³èŠä»€ä¹ˆå°±èŠä»€ä¹ˆæ‰å¯¹ï¼Œæˆ‘ä¸çˆ±å¬åˆéè¦å¬å¤šå°‘æ²¾ç‚¹äº†ğŸ˜Œ - è½¬å‘ @å¤šæ¬¡å©‰æ‹’ä¹…ä¿ç»‡ç»‡:&amp;ensp;å¦‚æœä½ ä»¬èŠä¹ƒæœ¨å‚å…¨æ˜¯è´Ÿé¢çš„è¾“å‡ºçš„è¯é‚£ä½ ä»¬...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o51vuhak4/">
    
    
    
    
    
      
    
    æƒ³äº†æƒ³è¿˜æ˜¯æˆ‘çš„é—®é¢˜ï¼Œæ˜æ˜æ˜¯æƒ³èŠä»€ä¹ˆå°±èŠä»€ä¹ˆæ‰å¯¹ï¼Œæˆ‘ä¸çˆ±å¬åˆéè¦å¬å¤šå°‘æ²¾ç‚¹äº†ğŸ˜Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å¤šæ¬¡å©‰æ‹’ä¹…ä¿ç»‡ç»‡<!-- raw HTML omitted -->:â€‚å¦‚æœä½ ä»¬èŠä¹ƒæœ¨å‚å…¨æ˜¯è´Ÿé¢çš„è¾“å‡ºçš„è¯<!-- raw HTML omitted -->é‚£ä½ ä»¬è¿˜æ˜¯èŠæ¨±å‚å§ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O51wpcgno">æ›´æƒ³å›åˆ°å››å¹´å‰äº†é‚£ä¸ªæ—¶å€™æ²¡æœ‰è®¤è¯†è¿™ä¹ˆå¤šçš„äººä¹Ÿä¸ä¼šå¬åˆ°é‚£ä¹ˆå¤šä¼¤å¿ƒçš„è¯ç«‹ã¡ç›´ã‚Šä¸­</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o51wpcgno/">
    
    
    
    
    
      
    
    æ›´æƒ³å›åˆ°å››å¹´å‰äº†<!-- raw HTML omitted -->é‚£ä¸ªæ—¶å€™æ²¡æœ‰è®¤è¯†è¿™ä¹ˆå¤šçš„äºº<!-- raw HTML omitted -->ä¹Ÿä¸ä¼šå¬åˆ°é‚£ä¹ˆå¤šä¼¤å¿ƒçš„è¯<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç«‹ã¡ç›´ã‚Šä¸­<!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O52cS8Ziz">æƒ³åƒå§å§åšçš„é¥­</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o52cs8ziz/">
    
    
    
    
    
      
    
    æƒ³åƒå§å§åšçš„é¥­  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O4Wf56p9j">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.SENDAI8ch X é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o4wf56p9j/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.SENDAI8ch X <!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O4ZpCBlGL">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.ç»ªè¡Œè®° fb [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o4zpcblgl/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ç»ªè¡Œè®° fb &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1hnqowmtmpuj30u00u0mzh.jpg%22">https://tvax1.sinaimg.cn/large/006z6nxLgy1hnqowmtmpuj30u00u0mzh.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O5204Cm5h">è½‰ç™¼å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ3æœˆ15æ—¥ 18:00ã€œ18:30 (æ—¥æœ¬æ—¶é—´) SHOWROOMã€Œã®ããŠã³ã€ä¹…ä¿å²ç·’é‡Œ æ¾å°¾ç•™çš„ä½œä¸šæ˜¯ï¼šæœ‰ä»€ä¹ˆè¿˜æ²¡è¡¨æ¼”è¿‡çš„æƒ³è¦è¯•è¯•çœ‹...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o5204cm5h/">
    
    
    
    
    
      
    
    è½‰ç™¼å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->3æœˆ15æ—¥ 18:00ã€œ18:30 (æ—¥æœ¬æ—¶é—´) SHOWROOMã€Œã®ããŠã³ã€ä¹…ä¿å²ç·’é‡Œ <!-- raw HTML omitted -->æ¾å°¾ç•™çš„ä½œä¸šæ˜¯ï¼šæœ‰ä»€ä¹ˆè¿˜æ²¡è¡¨æ¼”è¿‡çš„æƒ³è¦è¯•è¯•çœ‹çš„äº‹å—ï¼Ÿ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O4VWnqJ6R">æ‰å†…å¯¿å­vsç¦äº•æ­£æ˜97å²vs80å²#å›´æ£‹#å›´æ£‹ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o4vwnqj6r/">
    
    
    
    
    
      
    
    æ‰å†…å¯¿å­vsç¦äº•æ­£æ˜<!-- raw HTML omitted --><!-- raw HTML omitted -->97å²vs80å²<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O4YoxaK9f">97å²çš„ç¬¬ä¸€åœºå¯¹å±€å¯æƒœæ²¡èƒ½è·èƒœ#å›´æ£‹#å›´æ£‹ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o4yoxak9f/">
    
    
    
    
    
      
    
    97å²çš„ç¬¬ä¸€åœºå¯¹å±€å¯æƒœæ²¡èƒ½è·èƒœ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O51wktAjY">å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šè¢«å°å­¦å››å¹´çº§çš„é™¢ç”Ÿé€†è½¬è€Œå¤§å“­â€”â€”åƒæ˜¥&amp;æ˜å¤çš„å¥³æ£‹æ‰‹é‚£äº›äº‹ï¼ˆ6ï¼‰ã€‹ #å›´æ£‹# å›´æ£‹ è¢«å°å­¦å››å¹´çº§çš„é™¢ç”Ÿé€†è½¬è€Œå¤§å“­â€”â€”åƒæ˜¥ï¼†æ˜å¤çš„å¥³æ£‹æ‰‹é‚£äº›äº‹...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o51wktajy/">
    
    
    
    
    
      
    
    å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šè¢«å°å­¦å››å¹´çº§çš„é™¢ç”Ÿé€†è½¬è€Œå¤§å“­â€”â€”åƒæ˜¥&amp;æ˜å¤çš„å¥³æ£‹æ‰‹é‚£äº›äº‹ï¼ˆ6ï¼‰ã€‹ <!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O4Vo6pZ8j">ä¹…ä¿å²ç»ªé‡Œvia.SENDAI8ch X é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o4vo6pz8j/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.SENDAI8ch X <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/t">https://h5.sinaimg.cn/upload/2015/09/25/3/t</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O4YSDugai">ä¹…ä¿å²ç»ªé‡Œ[å…¨åŠ›ä»¥èµ´] - è½¬å‘ @ä¹ƒæœ¨å‚46:&amp;ensp;ğŸ“¸#ä¹ƒæœ¨å‚46GALLERY#ğŸ“¸[æŠ±ä¸€æŠ±]#3æœŸç”Ÿ# Works[æŠ±ä¸€æŠ±]ä¹ƒæœ¨å‚46 #ä¹…ä¿å²ç»ªé‡Œ# #é˜ªå£ç ç¾# #ä½è—¤æ«# [å›¾ç‰‡][å›¾...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o4ysdugai/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;blo &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O4ZlV7hDi">ä¹…ä¿å²ç»ªé‡Œvia.ç»ªè¡Œè®° fb [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o4zlv7hdi/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ç»ªè¡Œè®° fb <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O51RrlrRe">ä¹…ä¿å²ç»ªé‡Œ3æœˆ15æ—¥ 18:00ã€œ18:30 (æ—¥æœ¬æ—¶é—´) SHOWROOMã€Œã®ããŠã³ã€ä¹…ä¿å²ç·’é‡Œ æ¾å°¾ç•™çš„ä½œä¸šæ˜¯ï¼šæœ‰ä»€ä¹ˆè¿˜æ²¡è¡¨æ¼”è¿‡çš„æƒ³è¦è¯•è¯•çœ‹çš„äº‹å—ï¼Ÿæˆ‘çš„è¯æ˜¯æƒ³é£èµ·æ¥ [å›¾ç‰‡][...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o51rrlrre/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->3æœˆ15æ—¥ 18:00ã€œ18:30 (æ—¥æœ¬æ—¶é—´) SHOWROOMã€Œã®ããŠã³ã€ä¹…ä¿å²ç·’é‡Œ <!-- raw HTML omitted -->æ¾å°¾ç•™çš„ä½œä¸šæ˜¯ï¼šæœ‰ä»€ä¹ˆè¿˜æ²¡è¡¨æ¼”è¿‡çš„æƒ³è¦è¯•è¯•çœ‹çš„äº‹å—ï¼Ÿæˆ‘çš„è¯æ˜¯æƒ³é£èµ·æ¥ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hnr0bszxr5j30xw0psju0.jp">https://tvax4.sinaimg.cn/large/006z6nxLgy1hnr0bszxr5j30xw0psju0.jp</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/7332621109/O4Zjsw0TC">æŸ¯æ´#é›…å±…ä¹æ¸…æ°´æ¹¾æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›##èµ›äº‹é¢„å‘Š# 2023é›…å±…ä¹æ¸…æ°´æ¹¾æ¯ä¸­å›½å›´æ£‹ç”²çº§è”èµ›å­£åèµ›ç¬¬ä¸‰è½®ç¬¬ä¸€å›åˆå°†äºæ˜å¤©ä¸­åˆåäºŒç‚¹åŠåœ¨å¹¿ä¸œçœæ·±åœ³å¸‚-æ·±åœ³æ·±èˆªå›½é™…é…’...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-7332621109-o4zjsw0tc/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æŸ¯æ´<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%9B%85%E5%B1%85%E4%B9%90%E6%B8%85%E6%B0%B4%E6%B9%BE%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E9%9B%85%E5%B1%85%E4%B9%90%E6%B8%85%E6%B0%B4%E6%B9%BE%E6%9D%AF%E4%B8%AD%E5%9B%BD%E5%9B%B4%E6%A3%8B%E7%94%B2%E7%BA%A7%E8</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.npr.org/2024/03/14/1198908629/a-symphony-of-resistance-throwback">A Symphony of Resistance (Throwback)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-14</span>
  </div>
  <div class="summary">
    <a href="/post/www-npr-org-2024-03-14-1198908629-a-symphony-of-resistance-throwback/">
    
    
    
    
    
      
    
    In 2011, the world was shaken by the Arab Spring, a wave of &ldquo;pro-democracy&rdquo; protests that spread throughout the Middle East and North Africa. The effects of the uprisings reverberated around the world as regimes fell in some countries, and civil war began in others. This week, we revisit the years leading up to the Arab Spring and its lasting impact on three people who lived through it.<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->To access bonus episodes and listen to Throughline sponsor-free, subscribe to Throughline+ via Apple Podcasts or at <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->plus.npr.org/throughline<!-- raw HTML omitted -->&lt; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38472430/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">Drusen in the macula and parapapillary region</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38472430-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The findings of this study, also taking into account its methodological limitations, suggest that macular drusen and parapapillary drusen shared the morphological feature of periodic-acid-Schiff-positive material between the RPE basal membrane and BM and that they did not vary significantly in choriocapillaris thickness and density. RPE cell density and BM thickness were higher in parapapillary drusen than in macular &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38472445/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">Alexis retractor efficacy in transthoracic thoracoscopically assisted discectomy for thoracic disc herniations</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38472445-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Use of the flexible and intuitive Alexis retractor maximises operative exposure and is an effective adjunct when performing complex transthoracic approaches for thoracic disc &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38472477/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38472477-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Systemic Mastocytosis (SM) is a multifaceted clinically heterogeneous disease. Advanced SM (AdvSM) comprises three entities: aggressive SM (ASM), mast cell leukaemia (MCL) and SM with an associated hematologic neoplasm (SM-AHN), the latter accounting for 60-70% of all AdvSM cases. Detection of a disease-triggering mutation in the KIT gene (esp. KIT D816V) in &gt;90% of the patients with ASM or SM-AHN has led to a significant improvement in therapeutic options by the implementation of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38472477/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240313180649&amp;v=2.18.0.post9&#43;e462414">Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38472477-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240313180649-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Systemic Mastocytosis (SM) is a multifaceted clinically heterogeneous disease. Advanced SM (AdvSM) comprises three entities: aggressive SM (ASM), mast cell leukaemia (MCL) and SM with an associated hematologic neoplasm (SM-AHN), the latter accounting for 60-70% of all AdvSM cases. Detection of a disease-triggering mutation in the KIT gene (esp. KIT D816V) in &gt;90% of the patients with ASM or SM-AHN has led to a significant improvement in therapeutic options by the implementation of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38472477/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240314180544&amp;v=2.18.0.post9&#43;e462414">Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38472477-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240314180544-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Systemic Mastocytosis (SM) is a multifaceted clinically heterogeneous disease. Advanced SM (AdvSM) comprises three entities: aggressive SM (ASM), mast cell leukaemia (MCL) and SM with an associated hematologic neoplasm (SM-AHN), the latter accounting for 60-70% of all AdvSM cases. Detection of a disease-triggering mutation in the KIT gene (esp. KIT D816V) in &gt;90% of the patients with ASM or SM-AHN has led to a significant improvement in therapeutic options by the implementation of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38472501/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">Feasibility of targeted therapies in the adjuvant setting of early breast cancer in men: real-world data from a population-based registry</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38472501-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: In a large real-world sample, more men with eBC are at clinical high risk according to the inclusion criteria of monarchE, NATALEE and OlympiA than would be expected in women. This is most likely due to more advanced stages at initial diagnosis in men. To evaluate whether CDK4/6 and PARP inhibitors improve prognosis also in men should be the topic of future real- world &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38472649/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">Liprin-Î± proteins are master regulators of human presynapse assembly</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38472649-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The formation of mammalian synapses entails the precise alignment of presynaptic release sites with postsynaptic receptors but how nascent cell-cell contacts translate into assembly of presynaptic specializations remains unclear. Guided by pioneering work in invertebrates, we hypothesized that in mammalian synapses, liprin-Î± proteins directly link trans-synaptic initial contacts to downstream steps. Here we show that, in human neurons lacking all four liprin-Î± isoforms, nascent synaptic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38472958/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">The Modified Ultrasound-Assisted Method: A Study of the Correlation between Magnetic Resonance Imaging and the Ultrasound-Assisted Evaluation of the Critical Shoulder Angle</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38472958-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Diagnosing the mCSA using sonography is a safe and valid method. No statistically significant differences between the results in MRI and sonography could be seen. Although this is a retrospective, single-center study including only Caucasian mid-Europeans, and with the known limitations of ultrasound imaging, it nevertheless shows that sonography can be used as a simple, cheap, and fast technique to assess a modified CSA, which shows very good correlation with the standard &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38473301/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">The Current Landscape of Prostate-Specific Membrane Antigen (PSMA) Imaging Biomarkers for Aggressive Prostate Cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38473301-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The review examines the vital role of prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in the diagnosis, staging, and treatment of prostate cancer (PCa). It focuses on the superior diagnostic abilities of PSMA PET/CT for identifying both nodal and distant PCa, and its potential as a prognostic indicator for biochemical recurrence and overall survival. Additionally, we focused on the variability of PSMA&rsquo;s expression and its impact on &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38473769/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">Stereoselective Analysis of the Antiseizure Activity of Fenfluramine and Norfenfluramine in Mice: Is &lt;em&gt;l&lt;/em&gt;-Norfenfluramine a Better Follow-Up Compound to Racemic-Fenfluramine?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38473769-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The aim of this study was to investigate the comparative antiseizure activity of the l-enantiomers of d,l-fenfluramine and d,l-norfenfluramine and to evaluate the relationship between their concentration in plasma and brain and anticonvulsant activity. d,l-Fenfluramine, d,l-norfenfluramine and their individual enantiomers were evaluated in the mouse maximal electroshock seizure (MES) test. d,l-Fenfluramine, d,l-norfenfluramine and their individual l-enantiomers were also assessed in the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38473790/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240314180544&amp;v=2.18.0.post9&#43;e462414">Evidence of the Role of Inflammation and the Hormonal Environment in the Pathogenesis of Adrenal Myelolipomas in Congenital Adrenal Hyperplasia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38473790-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240314180544-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Adrenal myelolipomas (AML) are composed of mature adipose and hematopoietic components. They represent approximately 3 percent of adrenal tumors and are commonly found in patients with congenital adrenal hyperplasia (CAH). CAH provides a unique environment to explore AML pathogenesis. We aimed to evaluate the role of the immune system and hormones that accumulate in poorly controlled CAH in the development of AML. When compared to normal adrenal tissue, CAH-affected adrenal tissue &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38474037/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">Protein Kinase D Plays a Crucial Role in Maintaining Cardiac Homeostasis by Regulating Post-Translational Modifications of Myofilament Proteins</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38474037-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Protein kinase D (PKD) enzymes play important roles in regulating myocardial contraction, hypertrophy, and remodeling. One of the proteins phosphorylated by PKD is titin, which is involved in myofilament function. In this study, we aimed to investigate the role of PKD in cardiomyocyte function under conditions of oxidative stress. To do this, we used mice with a cardiomyocyte-specific knock-out of Prkd1, which encodes PKD1 (Prkd1^(loxP/loxP); ^(Î±MHC-Cre); PKD1 cKO), as well as wild &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38474110/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">Exploring the Molecular Tapestry: Organ-Specific Peptide and Protein Ultrafiltrates and Their Role in Therapeutics</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38474110-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    This study aims to characterize the proteome composition of organ-derived protein extracts from rabbits. Protein isolation was performed using soft homogenization and size exclusion via ultrafiltration. The proteome analysis of the ultrafiltrates was conducted using gel electrophoresis, and the mass spectrometry data were subjected to gene ontology analysis. Proteomic profiling revealed comprehensive protein profiles associated with RNA regulation, fatty acid binding, inflammatory &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38474627/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">[Tc(NO)(Cp)(PPh&lt;sub&gt;3&lt;/sub&gt;)Cl] and [Tc(NO)(Cp)(PPh&lt;sub&gt;3&lt;/sub&gt;)(NCCH&lt;sub&gt;3&lt;/sub&gt;)](PF&lt;sub&gt;6&lt;/sub&gt;), and Their Reactions with Pyridine and Chalcogen Donors</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38474627-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Reactions of the technetium(I) nitrosyl complex [Tc(NO)(Cp)(PPh(3))Cl] with triphenylphosphine chalcogenides EPPh(3) (E = O, S, Se), and Ag(PF(6)) in a CH(2)Cl(2)/MeOH mixture (v/v, 2/1) result in an exchange of the chlorido ligand and the formation of <a href="PF(6)">Tc(NO)(Cp)(PPh(3))(EPPh(3))</a> compounds. The cationic acetonitrile complex [Tc(NO)(Cp)(PPh(3))(NCCH(3))]^(+) is formed when the reaction is conducted in NCCH(3) without additional ligands. During the isolation of the corresponding &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38475826/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">Low awareness of the transitivity assumption in complex networks of interventions: a systematic survey from 721 network meta-analyses</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38475826-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Overall, there has been a slight improvement in reporting and evaluating transitivity since releasing PRISMA-NMA, particularly in items related to the systematic review report. Nevertheless, there has been limited attention to pre-planning the transitivity evaluation and low awareness of the conceptual evaluation methods that align with the nature of the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38475994/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">SMXL5 attenuates strigolactone signaling in Arabidopsis thaliana by inhibiting SMXL7 degradation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38475994-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Hormone-activated proteolysis is a recurring theme of plant hormone signaling mechanisms. In strigolactone signaling, the enzyme-receptor DWARF14 (D14) and an F-box protein, MORE AXILLARY GROWTH2 (MAX2), mark SUPPRESSOR OF MAX2 1-LIKE (SMXL) family proteins SMXL6, SMXL7, and SMXL8 for rapid degradation. Removal of these transcriptional corepressors initiates downstream growth responses. The homologous proteins SMXL3, SMXL4, and SMXL5, however, are resistant to MAX2-mediated degradation. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38476298/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">Trackplot: a fast and lightweight R script for epigenomic enrichment plots</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38476298-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    MOTIVATION: BigWig files serve as essential inputs in epigenomic data visualization. However, current R packages for visualizing these files are limited, slow, and burdened by numerous &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38476441/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">Can acupuncture increase microcirculation in peripheral artery disease and diabetic foot syndrome? - a pilot study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38476441-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Globally, diabetes mellitus (DM) and peripheral artery disease (PAD) have an increasing incidence and a high prevalence and are both associated with high morbidity and complication rates, e.g., as chronic non-healing peripheral ulcers. Impaired macro- and microcirculation and peripheral neuropathy lead to an increased risk of foot ulcers and infections. These complications are difficult to treat, have a high risk of becoming chronic and often lead to lower limb amputation. The aim &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38476465/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">Assessing long-term, vestibulotoxic side effects after gentamicin therapy in neonatal sepsis or infection using video head impulse test</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38476465-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: and Relevance: Almost half of the children observed after having undergone gentamicin therapy as newborns showed abnormalities in VHIT, although they did not show any clinical signs of disbalance or vestibular hypofunction. VHIT can serve as a sensitive investigation method for the early screening of post-therapeutic vestibulotoxic side effects after gentamicin therapy in children. Additionally, VHIT can enable early intervention in these &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38476748/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38476748-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The treatment landscape of resectable early-stage non-small cell lung cancer (NSCLC) is set to change significantly due to encouraging results from randomized trials evaluating neoadjuvant and adjuvant immunotherapy, as well as adjuvant targeted therapy. As of January 2024, marketing authorization has been granted for four new indications in Europe, and regulatory approvals for other study regimens are expected. Because cost-effectiveness and reimbursement criteria for novel treatments &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38476749/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">Challenges and controversies in resectable non-small cell lung cancer: a clinician&#39;s perspective</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38476749-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The treatment landscape of resectable early-stage non-small cell lung cancer (NSCLC) is transforming due to the approval of novel adjuvant and neoadjuvant systemic treatments. The European Medicines Agency (EMA) recently approved adjuvant osimertinib, adjuvant atezolizumab, adjuvant pembrolizumab, and neoadjuvant nivolumab combined with chemotherapy, and the approval of other agents or new indications may follow soon. Despite encouraging results, many unaddressed questions remain. Moreover, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38477420/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">LRRK2 regulates ferroptosis through the system Xc-GSH-GPX4 pathway in the neuroinflammatory mechanism of Parkinson&#39;s disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38477420-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Parkinson&rsquo;s disease (PD) is the most prevalent neurodegenerative disorder. Neuroinflammation mediated by activated microglia and apoptosis of dopaminergic (DA) neurons in the midbrain are its primary pathological manifestations. Leucine-rich repeat protein kinase 2 (LRRK2) kinase has been observed to increase expression during neuroinflammation, however, the effect of LRRK2 on microglia activation remains poorly understood. In this study, we have established lipopolysaccharide (LPS) treated &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38477592/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240313180711&amp;v=2.18.0.post9&#43;e462414">Portal vein arterialization as a salvage method in advanced hepatopancreatobiliary surgery</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38477592-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240313180711-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38477994/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240313180702&amp;v=2.18.0.post9&#43;e462414">Maternal RSV Vaccine - Weighing Benefits and Risks</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38477994-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240313180702-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38477994/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240314180549&amp;v=2.18.0.post9&#43;e462414">Maternal RSV Vaccine - Weighing Benefits and Risks</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38477994-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240314180549-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38477995/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240313180702&amp;v=2.18.0.post9&#43;e462414">Lumasiran, Isolated Kidney Transplantation, and Continued Vigilance</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38477995-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240313180702-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38477995/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240314180549&amp;v=2.18.0.post9&#43;e462414">Lumasiran, Isolated Kidney Transplantation, and Continued Vigilance</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38477995-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240314180549-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38477996/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240313180702&amp;v=2.18.0.post9&#43;e462414">Pulsed Field Ablation for Paroxysmal Atrial Fibrillation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38477996-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240313180702-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38477996/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240314180549&amp;v=2.18.0.post9&#43;e462414">Pulsed Field Ablation for Paroxysmal Atrial Fibrillation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38477996-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240314180549-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38477997/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240313180702&amp;v=2.18.0.post9&#43;e462414">Pulsed Field Ablation for Paroxysmal Atrial Fibrillation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38477997-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240313180702-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38477997/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240314180549&amp;v=2.18.0.post9&#43;e462414">Pulsed Field Ablation for Paroxysmal Atrial Fibrillation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38477997-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240314180549-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38477998/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240313180702&amp;v=2.18.0.post9&#43;e462414">Pulsed Field Ablation for Paroxysmal Atrial Fibrillation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38477998-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240313180702-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38477998/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240314180549&amp;v=2.18.0.post9&#43;e462414">Pulsed Field Ablation for Paroxysmal Atrial Fibrillation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38477998-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240314180549-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38477999/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240313180702&amp;v=2.18.0.post9&#43;e462414">Pulsed Field Ablation for Paroxysmal Atrial Fibrillation. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38477999-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240313180702-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38477999/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240314180549&amp;v=2.18.0.post9&#43;e462414">Pulsed Field Ablation for Paroxysmal Atrial Fibrillation. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38477999-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240314180549-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38478000/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240313180702&amp;v=2.18.0.post9&#43;e462414">Pulsed Field Ablation for Paroxysmal Atrial Fibrillation. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38478000-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240313180702-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38478000/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240314180549&amp;v=2.18.0.post9&#43;e462414">Pulsed Field Ablation for Paroxysmal Atrial Fibrillation. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38478000-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240314180549-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38478001/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240313180702&amp;v=2.18.0.post9&#43;e462414">Wearable Technology in Clinical Practice for Depressive Disorder</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38478001-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240313180702-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38478001/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240314180549&amp;v=2.18.0.post9&#43;e462414">Wearable Technology in Clinical Practice for Depressive Disorder</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38478001-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240314180549-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38478002/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240313180702&amp;v=2.18.0.post9&#43;e462414">Wearable Technology in Clinical Practice for Depressive Disorder</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38478002-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240313180702-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38478002/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240314180549&amp;v=2.18.0.post9&#43;e462414">Wearable Technology in Clinical Practice for Depressive Disorder</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38478002-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240314180549-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38478003/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240313180702&amp;v=2.18.0.post9&#43;e462414">Wearable Technology in Clinical Practice for Depressive Disorder</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38478003-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240313180702-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38478003/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240314180549&amp;v=2.18.0.post9&#43;e462414">Wearable Technology in Clinical Practice for Depressive Disorder</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38478003-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240314180549-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38478004/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240313180702&amp;v=2.18.0.post9&#43;e462414">Wearable Technology in Clinical Practice for Depressive Disorder. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38478004-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240313180702-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38478004/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240314180549&amp;v=2.18.0.post9&#43;e462414">Wearable Technology in Clinical Practice for Depressive Disorder. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38478004-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240314180549-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38478005/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240313180702&amp;v=2.18.0.post9&#43;e462414">Concern about Tominersen in Patients with Huntington&#39;s Disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38478005-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240313180702-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38478005/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240314180549&amp;v=2.18.0.post9&#43;e462414">Concern about Tominersen in Patients with Huntington&#39;s Disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38478005-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240314180549-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38478006/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240313180702&amp;v=2.18.0.post9&#43;e462414">Concern about Tominersen in Patients with Huntington&#39;s Disease. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38478006-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240313180702-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38478006/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240314180549&amp;v=2.18.0.post9&#43;e462414">Concern about Tominersen in Patients with Huntington&#39;s Disease. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38478006-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240314180549-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38478007/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240313180702&amp;v=2.18.0.post9&#43;e462414">The Journal&#39;s Historical &#34;Indian Problem&#34;</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38478007-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240313180702-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38478007/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240314180549&amp;v=2.18.0.post9&#43;e462414">The Journal&#39;s Historical &#34;Indian Problem&#34;</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38478007-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240314180549-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38478008/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240313180702&amp;v=2.18.0.post9&#43;e462414">Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38478008-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240313180702-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38478008/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240314180549&amp;v=2.18.0.post9&#43;e462414">Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38478008-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240314180549-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38478750/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1T_hRitDi640TP2h3NSbMGoRgaQy0YbKptUmBh6PxMMLuIN9H_&amp;fc=20220919194940&amp;ff=20240314180506&amp;v=2.18.0.post9&#43;e462414">Rapid cycle deliberate practice: application in forceps simulation training for gynecology and obstetrics residents</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38478750-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1t-hritdi640tp2h3nsbmgorgaqy0ybkptumbh6pxmmluin9h-fc-20220919194940-ff-20240314180506-v-2-18-0-post9-e/">
    
    
    
    
    
      
    
    CONCLUSIONS: RCDP exhibits immediate efficacy in elevating forceps delivery skills among residents. However, sustained skill enhancement necessitates innovative approaches, while RCDP&rsquo;s value lies in tailored feedback and reflection for enriched medical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38479811/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">Location- and Object-based representational mechanisms account for bilateral field advantage in multiple object tracking</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38479811-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Keeping track of multiple visually identical and independently moving objects is a remarkable feature of the human visual system. Theoretical accounts for this ability focus on resource-based models that describe parametric decreases of performance with increasing demands during the task (i.e. more relevant items, closer distances, higher speed). Additionally, the presence of two central tracking resources, one within each hemisphere, has been proposed, allowing for an independent maintenance &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38479934/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">Malnutrition and vitamin deficiencies after surgery for esophageal and gastric cancer: A metanalysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38479934-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Patients from these groups are at risk for vitamin deficiencies. A guideline on postoperative supplementation is &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38480016/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">Effect of a calibration aid and the intraoral scanner on the registration of a partially edentulous maxilla: An in vitro study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38480016-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Scanning accuracy depends on the scanner and the calibration aid used, in particular, for spans exceeding a single &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38480203/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240314180555&amp;v=2.18.0.post9&#43;e462414">On the status of Helicops wettsteini Amaral, 1929, a senior synonym of Hypsiscopus murphyi (SERPENTES: Homalopsidae)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38480203-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240314180555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We redescribe the name-bearing types of Helicops wettsteini Amaral, 1929, a species described from central Costa Rica. However, while Helicops wettsteini has been considered in the literature a synonym of Hypsiscopus plumbeus (previously Enhydris plumbea), we present here morphological evidence for considering Helicops wettsteini a synonym of the recently described species Hypsiscopus murphyi Bernstein, Voris, Stuart, Phimmachak, Seateun, Sivongxay, Neang, Karns, Andrews, Osterhage, Phipps &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O4MbOzv8x">é‡è¦çš„å…¨çƒäººå£ã€å¥åº·å’Œæ­»äº¡ç ”ç©¶ã€‚ä»Šå¤©LancetåˆŠç™»äº†ä¸€ä¸ªååˆ†é‡è¦çš„ç ”ç©¶ï¼Œæ˜¯æ–°å† ç–«æƒ…ä¸­åšå‡ºå“è¶Šè´¡çŒ®çš„IHMEå‘è¡¨çš„ä¸€ä¸ªå¤§å‹å…¨çƒäººå£å­¦ç ”ç©¶ã€‚è¿™é¡¹ç ”ç©¶é€šè¿‡å»ºæ¨¡å…¨é¢è¯„...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o4mbozv8x/">
    
    
    
    
    
      
    
    é‡è¦çš„å…¨çƒäººå£ã€å¥åº·å’Œæ­»äº¡ç ”ç©¶ã€‚ä»Šå¤©LancetåˆŠç™»äº†ä¸€ä¸ªååˆ†é‡è¦çš„ç ”ç©¶ï¼Œæ˜¯æ–°å† ç–«æƒ…ä¸­åšå‡ºå“è¶Šè´¡çŒ®çš„IHMEå‘è¡¨çš„ä¸€ä¸ªå¤§å‹å…¨çƒäººå£å­¦ç ”ç©¶ã€‚è¿™é¡¹ç ”ç©¶é€šè¿‡å»ºæ¨¡å…¨é¢è¯„ä¼°äº†æ–°å† ç–«æƒ…å¯¹äººç±»å¥åº·å’Œå¯¿å‘½çš„å½±å“ï¼Œå› æ­¤å…·æœ‰ä¸¾è¶³è½»é‡çš„æ„ä¹‰ï¼Œå®ƒæç¤ºäº†ç™¾å¹´ä¸€é‡çš„å…¨çƒé‡å¤§ç–«æƒ…å¯¹äººç±»å¥åº·çš„æ·±è¿œå½±å“ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->è¿™é¡¹ç ”ç©¶å½•å…¥äº†22223ä¸ªæ•°æ®åº“æ•°æ®ï¼Œåˆ†æäº†2026ä¸ªæ•°æ®åº“çš„å¯ç”¨æ•°æ®ï¼Œæœ€ç»ˆç”¨ST-GPRåˆ†æäº†æ¥è‡ªå…¨çƒ30763åœ°ç‚¹/å¹´çš„äººå£ç™»è®°è®°å½•å’Œæ ·æœ¬ç™»è®°æ•°æ®ã€355 æ¬¡äººå£æ™®æŸ¥ä»¥åŠ24ä¸ªæ¥æºæˆäººæ­»äº¡ç‡è®°å½•ï¼Œä»è€Œè®¡ç®—å‡ºäº†1950-2021å¹´ç–«æƒ…ä¸­çš„è¶…é¢æ­»äº¡å’Œé¢„æœŸæ­»äº¡ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->ç ”ç©¶å‘ç°1950å¹´è‡³2021å¹´ï¼Œå…¨çƒæ­»äº¡ç‡å˜åŒ–åˆ†ä¸º2019å¹´å‰åä¸¤ä¸ªæ—¶æœŸã€‚1950-2019å¹´ï¼Œå…¨çƒæ¯ä¸ªå¹´é¾„æ®µæ­»äº¡ç‡éƒ½åœ¨é€æ¸ä¸‹é™ï¼›ä½†2019-2021å¹´çš„å…¨çƒäººå£æ­»äº¡ç‡å‘ç”Ÿåå¼¹ï¼Œç„¶è€Œå„¿ç«¥æ­»äº¡ç‡ä¾ç„¶æŒç»­ä¸‹é™ã€‚1950-2021å¹´ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O4N3M8guK">ä»Šå¤©å’ŒåŒäº‹è®¨è®ºäº†æ–°å‹å† çŠ¶ç—…æ¯’SARS-CoV-2çš„çªå˜æ ªï¼Œä¸»è¦æ˜¯å»å¹´çš„XBB.1.5å’Œç°åœ¨çš„JN.1ã€‚XBB.1.5æ˜¯å»å¹´æµè¡Œçš„çªå˜æ ªï¼Œä¹Ÿæ˜¯ç›®å‰çš„ç–«è‹—æ‰€åº”ç”¨çš„çªå˜æ ªSpikeç±»å‹ï¼›JN....</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o4n3m8guk/">
    
    
    
    
    
      
    
    ä»Šå¤©å’ŒåŒäº‹è®¨è®ºäº†æ–°å‹å† çŠ¶ç—…æ¯’SARS-CoV-2çš„çªå˜æ ªï¼Œä¸»è¦æ˜¯å»å¹´çš„XBB.1.5å’Œç°åœ¨çš„JN.1ã€‚XBB.1.5æ˜¯å»å¹´æµè¡Œçš„çªå˜æ ªï¼Œä¹Ÿæ˜¯ç›®å‰çš„ç–«è‹—æ‰€åº”ç”¨çš„çªå˜æ ªSpikeç±»å‹ï¼›JN.1æ˜¯ç›®å‰æµè¡Œçš„çªå˜æ ªï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ç½‘é¡µé“¾æ¥<!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼‰ï¼Œæ˜¯BA.2.86çš„åä»£ã€‚XBB.1.5è·¨è¶Šåˆ°JN.1å…·æœ‰æå¤§çš„å…ç–«åŸæ€§å˜åŒ–ï¼ŒWHOå»å¹´åäºŒæœˆå‘å‡ºçš„å…¬å‘ŠæŒ‡ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O4NQ4uen4">ä¸€ä¸ªæ¯6ä¸ªæœˆæ²»ç–—ä¸€æ¬¡çš„è¶…é•¿æ•ˆHIVæŠ—ç—…æ¯’ç»„åˆçš„åˆæ­¥ä¸´åºŠç»“æœè¢«å…¬å¸ƒã€‚ä»Šå¤©Lancet HIVå‘è¡¨äº†ä¸€ç¯‡ååˆ†é‡è¦çš„HIVæ²»ç–—ä¸´åºŠç ”ç©¶ï¼Œæ¥è‡ªRUçš„Marina Caskeyç­‰äººï¼ŒæŠ¥é“äº†RUå¼€...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o4nq4uen4/">
    
    
    
    
    
      
    
    ä¸€ä¸ªæ¯6ä¸ªæœˆæ²»ç–—ä¸€æ¬¡çš„è¶…é•¿æ•ˆHIVæŠ—ç—…æ¯’ç»„åˆçš„åˆæ­¥ä¸´åºŠç»“æœè¢«å…¬å¸ƒã€‚ä»Šå¤©Lancet HIVå‘è¡¨äº†ä¸€ç¯‡ååˆ†é‡è¦çš„HIVæ²»ç–—ä¸´åºŠç ”ç©¶ï¼Œæ¥è‡ªRUçš„Marina Caskeyç­‰äººï¼ŒæŠ¥é“äº†RUå¼€å‘çš„3BNC117å’Œ10-1074ä¸¤ç§å•æŠ—ä¸Gileadå¼€å‘çš„Lenacapavirè”åˆä½¿ç”¨ï¼Œä½œä¸ºæ¯6ä¸ªæœˆæ³¨å°„ä¸€æ¬¡çš„è¶…é•¿æ•ˆæŠ—ç—…æ¯’æ²»ç–—çš„1bæœŸä¸´åºŠè¯•éªŒï¼ˆNCT04811040ï¼‰ç»“æœã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->3BNC117å’Œ10-1074æ˜¯Nussenzweigç»„åœ¨2009å¹´åˆ†ç¦»çš„ï¼›åMartinç»„æŠ¥é“è¿™ä¸¤ä¸ªæŠ—ä½“ç»„åˆåœ¨æ’æ²³çŒ´ä¸­æœ‰æ½œåœ¨çš„æ²»æ„ˆåŠŸæ•ˆï¼ˆ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeli">https://h5.sinaimg.cn/upload/2015/09/25/3/timeli</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/O4SyF4FeX">å†™protocolå’Œåšå®éªŒçš„æ—¶å€™ï¼Œæˆ‘ä¸€å‘æ˜¯æœ€organizedï¼ŒOCD is my mojoã€‚æ‰€ä»¥å½“æˆ‘çœ‹åˆ°æ¯”æˆ‘æ›´organizedçš„äººçš„æ—¶å€™ï¼Œæˆ‘ä¼šå‰æ‰€æœªæœ‰åœ°æŠ“ç‹‚ã€‚</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-o4syf4fex/">
    
    
    
    
    
      
    
    å†™protocolå’Œåšå®éªŒçš„æ—¶å€™ï¼Œæˆ‘ä¸€å‘æ˜¯æœ€organizedï¼ŒOCD is my mojoã€‚æ‰€ä»¥å½“æˆ‘çœ‹åˆ°æ¯”æˆ‘æ›´organizedçš„äººçš„æ—¶å€™ï¼Œæˆ‘ä¼šå‰æ‰€æœªæœ‰åœ°æŠ“ç‹‚ã€‚  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O4SD5oavI">è”åˆå›½å¾ˆå¤šæŠ¥å‘Šå†™çš„å¾ˆè¯¦ç»†ï¼Œè¿™ä¹Ÿæ˜¯ä»¥è‰²åˆ—å¯¹è”åˆå›½åœ¨å·´å‹’æ–¯å¦æœºæ„æ¨ä¹‹å…¥éª¨çš„åŸå› ã€‚//@æœ¬å‘½å¥³ç¥é“¶ä¸´rechil:è‰¹ï¼Œç¬¬ä¸€æ¬¡è§åˆ°è¿™äº›å†…å®¹ï¼Œå›½å†…ä¸ç®¡å•¥å¹³å°ï¼Œä¸€è°ˆèµ·ä»¥è‰²åˆ—...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o4sd5oavi/">
    
    
    
    
    
      
    
    è”åˆå›½å¾ˆå¤šæŠ¥å‘Šå†™çš„å¾ˆè¯¦ç»†ï¼Œè¿™ä¹Ÿæ˜¯ä»¥è‰²åˆ—å¯¹è”åˆå›½åœ¨å·´å‹’æ–¯å¦æœºæ„æ¨ä¹‹å…¥éª¨çš„åŸå› ã€‚//<!-- raw HTML omitted -->@æœ¬å‘½å¥³ç¥é“¶ä¸´rechil<!-- raw HTML omitted -->:è‰¹ï¼Œç¬¬ä¸€æ¬¡è§åˆ°è¿™äº›å†…å®¹ï¼Œå›½å†…ä¸ç®¡å•¥å¹³å°ï¼Œä¸€è°ˆèµ·ä»¥è‰²åˆ—å°±æ˜¯å„ç§ç‰›é€¼ï¼Œå„ç§å‘è¾¾ï¼Œè¿™TMä¸å°±æ˜¯ä¸ªå¯„ç”Ÿè™«å—ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»ä¸ºä»€ä¹ˆè¯´â€œå»åˆ«äººæµ·å²¸çº¿æ¶ç‚®çš„æ—§æ®–æ°‘ä¸»ä¹‰â€å·²ç»è¿‡æ—¶äº†ï¼Ÿå› ä¸ºæˆæœ¬è¶Šæ¥è¶Šé«˜ã€æ”¶ç›Šè¶Šæ¥è¶Šä½ã€‚<!-- raw HTML omitted -->ğŸ”»ä¸¾ä¸ªæœ€æœ€ç®€å•çš„ä¾‹å­ï¼šä»¥è‰²åˆ—å¯¹å·´å‹’æ–¯å¦çš„å é¢†å’Œç»æµæ å¤ºï¼Œå¯ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O4SuFyQZd">çœ‹å‘¨æœ«æœ‰æ—¶é—´çš„è¯å»æŠŠL9ã€M9éƒ½è¯•äº†ã€‚å¦‚æœå»äº†ï¼Œåˆ°æ—¶å€™è°ˆè°ˆæ„Ÿæƒ³[æ€è€ƒ]//@æŸçƒŸ_estalydia:å»è¯•é©¾ä¸€ä¸‹å§ï¼ŒçœŸçš„ï¼Œä¸€æŠŠå­çˆ±ä¸Šã€‚è®ºç¡¬ä»¶bç«™æœ‰æ‹†è§£è§†é¢‘ï¼ŒçœŸæå®æ–™å…¨éƒ¨æ‹‰...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o4sufyqzd/">
    
    
    
    
    
      
    
    çœ‹å‘¨æœ«æœ‰æ—¶é—´çš„è¯å»æŠŠL9ã€M9éƒ½è¯•äº†ã€‚å¦‚æœå»äº†ï¼Œåˆ°æ—¶å€™è°ˆè°ˆæ„Ÿæƒ³<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@æŸçƒŸ_estalydia<!-- raw HTML omitted -->:å»è¯•é©¾ä¸€ä¸‹å§ï¼ŒçœŸçš„ï¼Œä¸€æŠŠå­çˆ±ä¸Šã€‚è®ºç¡¬ä»¶bç«™æœ‰æ‹†è§£è§†é¢‘ï¼ŒçœŸæå®æ–™å…¨éƒ¨æ‹‰æ»¡ï¼Œè®ºè½¯ä»¶æ›´æ˜¯é¥é¥é¢†å…ˆ<!-- raw HTML omitted -->&lt;img alt=&quot;[ç¬‘è€Œä¸è¯­]&quot; src=&ldquo;<a href="https://h5.sinai">https://h5.sinai</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O4Svv2fC6">ğŸ”»è®°è€…è¿™äº‹å„¿ï¼Œä¸å¥½è¯´ï¼Œéƒ½æœ‰å¯èƒ½ã€‚ğŸ”»æœªçŸ¥å…¨è²Œï¼Œæˆ‘æ²¡èµ„æ ¼å¦„ä¸‹ç»“è®ºã€‚ğŸ”»æ€»ä¹‹ï¼Œåœ¨å·¥ä½œä¸­è¦ä¸¥æ ¼æ‰§è¡Œç›¸å…³è§„å®šã€å¹¶ä¸”ä¿æŠ¤å¥½è‡ªå·±ï¼Œæ— è®ºæ˜¯è®°è€…ã€åŸºå±‚å·¥ä½œäººå‘˜è¿˜æ˜¯æ™®...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o4svv2fc6/">
    
    
    
    
    
      
    
    ğŸ”»è®°è€…è¿™äº‹å„¿ï¼Œä¸å¥½è¯´ï¼Œéƒ½æœ‰å¯èƒ½ã€‚<!-- raw HTML omitted -->ğŸ”»æœªçŸ¥å…¨è²Œï¼Œæˆ‘æ²¡èµ„æ ¼å¦„ä¸‹ç»“è®ºã€‚<!-- raw HTML omitted -->ğŸ”»æ€»ä¹‹ï¼Œåœ¨å·¥ä½œä¸­è¦ä¸¥æ ¼æ‰§è¡Œç›¸å…³è§„å®šã€å¹¶ä¸”ä¿æŠ¤å¥½è‡ªå·±ï¼Œæ— è®ºæ˜¯è®°è€…ã€åŸºå±‚å·¥ä½œäººå‘˜è¿˜æ˜¯æ™®é€šåƒç“œç¾¤ä¼—ï¼Œéƒ½ä¸€æ ·ã€‚<!-- raw HTML omitted -->ğŸ”»<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O4SyoEpMP">ğŸ”»ä¹‹å‰ä¿„å†›æ‰“æ‰ä¸¤æ¶ä¹Œå†›ç›´å‡æœºçš„åç»­ï¼šæˆ˜åœºç›‘è§†æ— äººæœºæ²¡æ’¤ï¼Œæ‹åˆ°ä¹Œå†›æ¥æ‰“æ‰«æˆ˜åœºï¼ŒæŠŠæ®‹éª¸é‡Œçš„å¼¹è¯æ”¶æ‹¾äº†ï¼Œå¼€è½¦æ’¤äº†ã€‚ğŸ”»ä¿„å†›æ— äººæœºå°±è·Ÿç€æ’¤é€€çš„ä¹Œå†›å¡è½¦ï¼Œä¸€è·¯...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o4syoepmp/">
    
    
    
    
    
      
    
    ğŸ”»ä¹‹å‰ä¿„å†›æ‰“æ‰ä¸¤æ¶ä¹Œå†›ç›´å‡æœºçš„åç»­ï¼šæˆ˜åœºç›‘è§†æ— äººæœºæ²¡æ’¤ï¼Œæ‹åˆ°ä¹Œå†›æ¥æ‰“æ‰«æˆ˜åœºï¼ŒæŠŠæ®‹éª¸é‡Œçš„å¼¹è¯æ”¶æ‹¾äº†ï¼Œå¼€è½¦æ’¤äº†ã€‚<!-- raw HTML omitted -->ğŸ”»ä¿„å†›æ— äººæœºå°±è·Ÿç€æ’¤é€€çš„ä¹Œå†›å¡è½¦ï¼Œä¸€è·¯è·Ÿåˆ°äº†éšè—çš„åŸºåœ°ï¼Œåˆå¬å”¤ç«åŠ›æ¥æŠŠåŸºåœ°ç­äº†ã€‚<!-- raw HTML omitted -->ğŸ”»æˆ˜åœºå•å‘é€æ˜å°±æ˜¯è¿™ä¹ˆå“ˆäººã€‚<!-- raw HTML omitted -->ğŸ”»æºï¼šĞ˜Ğ—ĞĞĞĞšĞ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;sourc &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O4T2Hr1Tr">ğŸ”»çœ‹äº†ä¸‹æ€»å°çš„å‡ è·¯ç›´æ’­ä¿¡å·ï¼Œç»™æ²¡æœ‰çœ‹ç›´æ’­çš„ç½‘å‹åšä¸ªç®€å•åˆ‡ç‰‡ï¼šğŸ”»ä¸€è·¯æ˜¯å›¾1çš„CCTV-2ï¼Œç°åœºè®°è€…æ˜¯æ¨æµ·çµï¼ŒèŠ‚ç›®æœ‰æ—¶é—´æˆ³ï¼Œå¯ä»¥çœ‹åˆ°å…·ä½“çš„æ—¶é—´ç‚¹æ˜¯12:12:00ã€‚...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o4t2hr1tr/">
    
    
    
    
    
      
    
    ğŸ”»çœ‹äº†ä¸‹æ€»å°çš„å‡ è·¯ç›´æ’­ä¿¡å·ï¼Œç»™æ²¡æœ‰çœ‹ç›´æ’­çš„ç½‘å‹åšä¸ªç®€å•åˆ‡ç‰‡ï¼š<!-- raw HTML omitted -->ğŸ”»ä¸€è·¯æ˜¯å›¾1çš„CCTV-2ï¼Œç°åœºè®°è€…æ˜¯æ¨æµ·çµï¼ŒèŠ‚ç›®æœ‰æ—¶é—´æˆ³ï¼Œå¯ä»¥çœ‹åˆ°å…·ä½“çš„æ—¶é—´ç‚¹æ˜¯12:12:00ã€‚<!-- raw HTML omitted -->ğŸ”»å¦ä¸€è·¯æ˜¯<!-- raw HTML omitted -->@å¤®è§†æ–°é—»<!-- raw HTML omitted --> 11:06 åœ¨å¾®åšå¼€å¯çš„3ä¸ªå¤šå°æ—¶ç›´æ’­ï¼ˆå›¾2ï¼‰ã€‚<!-- raw HTML omitted -->ğŸ”»åœ¨ç›´æ’­æ—¶é•¿00:03:10ï¼ˆ11:06:00+00:03:10ï¼‰ï¼Œè®¸æ¢¦å“²è®°è€…å·²ç»å¾ˆé è¿‘çˆ†ç‚¸ç°åœºäº†ï¼ˆå›¾3ï¼‰ï¼Œåœ¨00:03:37ï¼ˆ11:06:00+00:03:37ï¼‰ï¼Œç»ç°åœºæ¶ˆé˜²äººå‘˜æé†’ï¼ˆå›¾4ï¼‰ï¼Œè®°è€…å¾ˆå¿«é€€å‡ºäº†ç°åœºï¼Œåœ¨00:05:07ï¼ˆ11:06:00+00:05:07ï¼‰èµ°åˆ°äº†å¤–å›´åº”è¯¥æ˜¯ç›¸å¯¹è¾ƒå®‰å…¨çš„ä½ç½®ï¼ˆå›¾5ï¼‰ã€‚<!-- raw HTML omitted -->ğŸ”»æ­¤åï¼Œè®¸æ¢¦å“²è®°è€…ä¸€ç›´åœ¨ç°åœºé‡‡è®¿ï¼Œåœ¨ç›´æ’­æ—¶é•¿00:35:41ï¼ˆ11:06:00+00:35:41ï¼‰æ—¶ï¼Œæ¨æµ·çµè®°è€…ä¹Ÿåœ¨&lt;a href=&ldquo;<a href="https://weibo.com/n/%E5%A4%AE%E8%25A">https://weibo.com/n/%E5%A4%AE%E8%A</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O4TaYl64V">æ³¨ï¼šä»¥ä¸Šæ˜¯å¯¹å¤®è§†ç›´æ’­3å°æ—¶ç›´æ’­å†…å®¹ä¸ºä¸»çš„åˆ‡ç‰‡å®¢è§‚é™ˆè¿°ï¼Œæ²¡æœ‰å¯¹â€œå„æ–¹å¯¹é”™ä¸å¦â€çš„ä»»ä½•è¯„ä»·ã€‚ç›®å‰ä¿¡æ¯æœ‰é™ï¼Œä½œä¸ºè·¯äººç½‘å‹ï¼Œæ— æ³•ä¹Ÿæ— èµ„æ ¼è¿›è¡Œè¯„ä»·ï¼Œå‘¨çŸ¥ã€‚ - è½¬å‘...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o4tayl64v/">
    
    
    
    
    
      
    
    æ³¨ï¼šä»¥ä¸Šæ˜¯å¯¹å¤®è§†ç›´æ’­3å°æ—¶ç›´æ’­å†…å®¹ä¸ºä¸»çš„åˆ‡ç‰‡å®¢è§‚é™ˆè¿°ï¼Œæ²¡æœ‰å¯¹â€œå„æ–¹å¯¹é”™ä¸å¦â€çš„ä»»ä½•è¯„ä»·ã€‚ç›®å‰ä¿¡æ¯æœ‰é™ï¼Œä½œä¸ºè·¯äººç½‘å‹ï¼Œæ— æ³•ä¹Ÿæ— èµ„æ ¼è¿›è¡Œè¯„ä»·ï¼Œå‘¨çŸ¥ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»çœ‹äº†ä¸‹æ€»å°çš„å‡ è·¯ç›´æ’­ä¿¡å·ï¼Œç»™æ²¡æœ‰çœ‹ç›´æ’­çš„ç½‘å‹åšä¸ªç®€å•åˆ‡ç‰‡ï¼š<!-- raw HTML omitted -->ğŸ”»ä¸€è·¯æ˜¯å›¾1çš„CCTV-2ï¼Œç°åœºè®°è€…æ˜¯æ¨æµ·çµï¼ŒèŠ‚ç›®æœ‰æ—¶é—´æˆ³ï¼Œå¯ä»¥çœ‹åˆ°å…·ä½“çš„æ—¶é—´ç‚¹æ˜¯12:12:00ã€‚<!-- raw HTML omitted -->ğŸ”»å¦ä¸€è·¯æ˜¯<!-- raw HTML omitted -->@å¤®è§†æ–°é—»<!-- raw HTML omitted --> 11:06 åœ¨å¾®åšå¼€å¯çš„3ä¸ªå¤šå°æ—¶ç›´æ’­ï¼ˆå›¾2ï¼‰ã€‚<!-- raw HTML omitted -->ğŸ”»åœ¨ç›´æ’­æ—¶é•¿00:03:10ï¼ˆ11:06:00+00:03:10ï¼‰ï¼Œè®¸æ¢¦å“²è®°è€…å·²ç»å¾ˆé è¿‘çˆ†ç‚¸ç°åœºäº†ï¼ˆå›¾3ï¼‰ï¼Œåœ¨00:03:3 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O4THKpSRf">ğŸ”»ç¡å‰ç”¨ipadç®€å•æ¶‚äº†ä¸€ä¸‹ï¼Œmegaæ˜¯å› ä¸ºé£é˜»æ‰€ä»¥åˆ°è½¦å°¾è¦ä¸‹æ²‰ä¸€ä¸‹å—ï¼Ÿä½†æ˜¯æ„Ÿè§‰è¿™æ ·æ‹±èµ·çš„é€ å‹å…¶å®ä¸æµç•…ã€‚ğŸ”»æ‹‰å¹³äº†æ„Ÿè§‰å¥½å¾ˆå¤š[å“†å•¦Aæ¢¦åƒæƒŠ]ï¼Œç©ºé—´æ˜¯ä¸æ˜¯è¿˜å¤§...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o4thkpsrf/">
    
    
    
    
    
      
    
    ğŸ”»ç¡å‰ç”¨ipadç®€å•æ¶‚äº†ä¸€ä¸‹ï¼Œmegaæ˜¯å› ä¸ºé£é˜»æ‰€ä»¥åˆ°è½¦å°¾è¦ä¸‹æ²‰ä¸€ä¸‹å—ï¼Ÿä½†æ˜¯æ„Ÿè§‰è¿™æ ·æ‹±èµ·çš„é€ å‹å…¶å®ä¸æµç•…ã€‚<!-- raw HTML omitted -->ğŸ”»æ‹‰å¹³äº†æ„Ÿè§‰å¥½å¾ˆå¤š<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼Œç©ºé—´æ˜¯ä¸æ˜¯è¿˜å¤§äº† <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O4TI7w40B">[å“†å•¦Aæ¢¦å®³æ€•] - è½¬å‘ @å¤®è§†æ–°é—»:&amp;ensp;ã€#ç‡•éƒŠçˆ†ç‡ƒäº‹æ•…è‡´7æ­»27ä¼¤#ã€‘3æœˆ13æ—¥7æ—¶54åˆ†ï¼Œæ²³åŒ—å»ŠåŠä¸‰æ²³å¸‚ç‡•éƒŠé•‡å‘ç”Ÿä¸€èµ·çˆ†ç‡ƒäº‹æ•…ã€‚æˆªè‡³13æ—¥23æ—¶ï¼Œç°åœºæ•‘æ´å·¥ä½œå·²åŸºæœ¬...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o4ti7w40b/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å¤®è§†æ–°é—»<!-- raw HTML omitted -->:â€‚ã€&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%87%95%E9%83%8A%E7%88%86%E7%87%83%E4%BA%8B%E6%95%85%E8%87%B47%E6%AD%BB27%E4%BC%A4%23&amp;amp;extparam=%23%E7%87%95%E9%83%8A%E7%88%86%E7%87%83%E4%BA%8B%E6%95%85%E8%87%B47%E6">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E7%87%95%E9%83%8A%E7%88%86%E7%87%83%E4%BA%8B%E6%95%85%E8%87%B47%E6%AD%BB27%E4%BC%A4%23&amp;amp;extparam=%23%E7%87%95%E9%83%8A%E7%88%86%E7%87%83%E4%BA%8B%E6%95%85%E8%87%B47%E6</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O4TmgF1EK">ğŸ”»å¦å¤–ï¼Œå·²ç»å¼€å§‹åœ¨ç½‘ä¸Šä¼ æ’­çš„å›¾1ä¸å±å®ï¼Œå›¾9æ‰æ˜¯å®é™…æƒ…å†µã€‚ğŸ”»æ ¹æ®@å¤®è§†æ–°é—» 11:06:00 åœ¨å¾®åšå¼€å¯çš„3ä¸ªå¤šå°æ—¶ç›´æ’­ä¸­ï¼Œä¸€å¼€å§‹æ€»å°çš„è®¸æ¢¦å“²è®°è€…å°±ä»‹ç»ï¼šâ€œç°åœ¨...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o4tmgf1ek/">
    
    
    
    
    
      
    
    ğŸ”»å¦å¤–ï¼Œå·²ç»å¼€å§‹åœ¨ç½‘ä¸Šä¼ æ’­çš„å›¾1ä¸å±å®ï¼Œå›¾9æ‰æ˜¯å®é™…æƒ…å†µã€‚<!-- raw HTML omitted -->ğŸ”»æ ¹æ®<!-- raw HTML omitted -->@å¤®è§†æ–°é—»<!-- raw HTML omitted --> 11:06:00 åœ¨å¾®åšå¼€å¯çš„3ä¸ªå¤šå°æ—¶ç›´æ’­ä¸­ï¼Œä¸€å¼€å§‹æ€»å°çš„è®¸æ¢¦å“²è®°è€…å°±ä»‹ç»ï¼šâ€œç°åœ¨å•Šï¼Œæˆ‘ç°åœ¨ç¦»è¿™ä¸ªå•†é“ºç›®æµ‹å·®ä¸å¤šä¸€ç™¾ç±³â€ï¼ˆå›¾2ï¼‰<!-- raw HTML omitted -->ğŸ”»åœ¨00:02:22ï¼Œè®°è€…åˆ°è¾¾äº†æ ¸å¿ƒåŒºåŸŸçš„æ¥¼å‰ï¼ˆå›¾3ï¼‰ï¼Œåœ¨00:03:06ï¼Œåˆ°è¾¾äº†å›¾4ä½ç½®ï¼Œåœ¨00:03:35ç»æ¶ˆé˜²äººå‘˜æé†’ç¦»å¼€äº†å›¾5æ ¸å¿ƒåŒºï¼Œåˆ°è¾¾äº†å›¾6ï¼Œå†æ¬¡ç»æé†’å±é™©åé€€åˆ°äº†å›¾7ã€‚<!-- raw HTML omitted -->ğŸ”»åœ¨01:04:37ï¼Œå¯ä»¥çœ‹åˆ°è®°è€…åˆæ¥åˆ°äº†æ ¸å¿ƒåŒºæ—è¾¹çš„é—¨å¸‚æˆ¿ä½ç½®æ‹æ‘„ï¼ˆå›¾8ï¼‰ï¼Œä»å›¾9èˆªæ‹çš„ä½ç½®æ ‡æ³¨å›¾å°±å¯ä»¥çœ‹å‡ºï¼Œè®°è€…å®é™…çš„é‡‡è®¿å’Œæ‹æ‘„ä½ç½®ï¼Œä¸ç½‘ä¼ çš„å›¾1å®Œå…¨ä¸ç¬¦ã€‚<!-- raw HTML omitted -->ğŸ”»å› æ­¤ï¼Œåœ¨å›¾1å®Œå…¨ä¼ æ’­å¼€ä¹‹å‰ï¼Œåº”äºˆä»¥çº æ­£ã€‚<!-- raw HTML omitted -->ğŸ”»å›¾2-9è§†é¢‘æ¥æºè§ï¼š<!-- raw HTML omitted -->@å¤®è§†æ–°é—»<!-- raw HTML omitted --> ä¸‰å°æ—¶ç›´æ’­è§†é¢‘ <!-- raw HTML omitted --> &lt;a href=&ldquo;<a href="https://weibo.com/2656274875/50">https://weibo.com/2656274875/50</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/O4TyPaMXq">ğŸ”»ä¸‰å°æ—¶ç›´æ’­çš„å¦ä¸€ä¸ªç»†èŠ‚æ˜¯ï¼šåœ¨ç›´æ’­æ—¶é•¿58:45ï¼Œè®°è€…å‘ç°ï¼šç°åœºåˆå‡ºç°æ˜ç«ï¼Œä¸è€ƒè™‘ç›´æ’­æ˜¯å¦å­˜åœ¨å»¶è¿Ÿï¼Œæ­¤æ—¶çš„æ—¶é—´æ˜¯12:14ï¼Œè€ŒCCTV-2è¿çº¿æ˜¯12:12ï¼ˆå›¾3ï¼‰ï¼Œè€ƒè™‘åˆ°...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-o4typamxq/">
    
    
    
    
    
      
    
    ğŸ”»ä¸‰å°æ—¶ç›´æ’­çš„å¦ä¸€ä¸ªç»†èŠ‚æ˜¯ï¼šåœ¨ç›´æ’­æ—¶é•¿58:45ï¼Œè®°è€…å‘ç°ï¼šç°åœºåˆå‡ºç°æ˜ç«ï¼Œä¸è€ƒè™‘ç›´æ’­æ˜¯å¦å­˜åœ¨å»¶è¿Ÿï¼Œæ­¤æ—¶çš„æ—¶é—´æ˜¯12:14ï¼Œè€ŒCCTV-2è¿çº¿æ˜¯12:12ï¼ˆå›¾3ï¼‰ï¼Œè€ƒè™‘åˆ°åœ¨è®°è€…å‘ç°ä¹‹å‰ï¼Œæ°´æªé˜µå·²ç»æ¶å¥½ï¼Œæ¶ˆé˜²å‘ç°å‡ºç°æ˜ç«æ—¶é—´åº”æ—©äº12:14ï¼Œä¸CCTV-2è¿çº¿æ—¶é—´å¤§è‡´å»åˆã€‚<!-- raw HTML omitted -->ğŸ”»ä»¥ä¸Šæ˜¯ç›´æ’­åˆ‡ç‰‡ä¸­å‘ç°çš„ç°åœºä¸€äº›çŠ¶å†µã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax3.sinaimg.cn/orj480/639b1bfbly1hnpzbo9d8nj">https://tvax3.sinaimg.cn/orj480/639b1bfbly1hnpzbo9d8nj</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O4NAQpygx">ç§‹åˆ€é±¼ä¹‹æ‰€ä»¥æ˜¯ç§‹åˆ€é±¼[èˆ”å±] [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o4naqpygx/">
    
    
    
    
    
      
    
    ç§‹åˆ€é±¼ä¹‹æ‰€ä»¥æ˜¯ç§‹åˆ€é±¼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O4NGrpxb6">ä¸­å›½å¥½åƒå”¯ç‹¬æ²¡æœ‰å±å…”çš„å† ä¸–ç•Œå† å†›ğŸ‘¿</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o4ngrpxb6/">
    
    
    
    
    
      
    
    ä¸­å›½å¥½åƒå”¯ç‹¬æ²¡æœ‰å±å…”çš„å† ä¸–ç•Œå† å†›ğŸ‘¿  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O4NOibHyC">å±å…”çš„ä¸–ç•Œå† å†›åªæœ‰ææ˜Œé•ä¸€ä¸ªäºº[æ€’]å…¶ä»–å±ç›¸éƒ½ä¸æ­¢ä¸€äººï¼Œé—®é¢˜å·²ç»å¾ˆæ˜æ˜¾äº†[æ€’]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o4noibhyc/">
    
    
    
    
    
      
    
    å±å…”çš„ä¸–ç•Œå† å†›åªæœ‰ææ˜Œé•ä¸€ä¸ªäºº<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å…¶ä»–å±ç›¸éƒ½ä¸æ­¢ä¸€äººï¼Œé—®é¢˜å·²ç»å¾ˆæ˜æ˜¾äº†<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O4NqNDlNn">ä¸¤å¤©æ”¹äº†ä¸‰åº§ğŸ’©å±±ğŸ‘¿</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o4nqndlnn/">
    
    
    
    
    
      
    
    ä¸¤å¤©æ”¹äº†ä¸‰åº§ğŸ’©å±±ğŸ‘¿  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/3825863518/O4NxGBrcO">æˆ‘ä¸€ç›´å¾ˆå›°æƒ‘ï¼Œè¿™Taco BellçœŸçš„æœ‰äººåƒå—ğŸ‘¿</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-3825863518-o4nxgbrco/">
    
    
    
    
    
      
    
    æˆ‘ä¸€ç›´å¾ˆå›°æƒ‘ï¼Œè¿™Taco BellçœŸçš„æœ‰äººåƒå—ğŸ‘¿  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O4RBA1L9b">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.seventeen å®˜ç½‘ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o4rba1l9b/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.seventeen å®˜ç½‘ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1hnpqgw5fuvj30ku0ogami.jpg%22">https://tvax3.sinaimg.cn/large/006z6nxLgy1hnpqgw5fuvj30ku0ogami.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O4SeWtGJj">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.ä¹ƒæœ¨å‚46 X [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o4sewtgjj/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ä¹ƒæœ¨å‚46 X &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1hnps723m3pj31kw16oqc2.jpg%22">https://tvax2.sinaimg.cn/large/006z6nxLgy1hnps723m3pj31kw16oqc2.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O4SeYhh51">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ#shiorigram# ç¨å25:00ï½ï¼ˆJSTï¼‰æ—¥æœ¬æ”¾é€ã€ä¹ƒæœ¨å‚46çš„ANNã€è¯·ä¸€å®šè¦å¬ï½ğŸ“» [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o4seyhh51/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;a">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23shiorigram%23&amp;a</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O4Sf64YWq">çˆ±å¬æ£’çƒçš„ä»Šæ™šæœ‰ç¦äº† - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.ä¹ƒæœ¨å‚46ann X [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o4sf64ywq/">
    
    
    
    
    
      
    
    çˆ±å¬æ£’çƒçš„ä»Šæ™šæœ‰ç¦äº†<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ä¹ƒæœ¨å‚46ann X &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1hnpsrb56psj316o1k">https://tvax1.sinaimg.cn/large/006z6nxLgy1hnpsrb56psj316o1k</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O4SgjyDV2">å·æ‹æ˜¯å§ï¼Œé“æš—æ‹ğŸ˜ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o4sgjydv2/">
    
    
    
    
    
      
    
    å·æ‹æ˜¯å§ï¼Œé“æš—æ‹ğŸ˜ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O4SHnDsHc">å“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆçº¸ç‰‡æ‹åœ¨é¢å¤´ä¸Šç¡®å®æ®‹å¿µå•Šå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆ - è½¬å‘ @çŸ­æ—¥æ¤ç‰©:&amp;ensp;ä¹…ä¿è§‰å¾—å‘¨å¹´liveä¸Šæœ€å€’éœ‰çš„äº‹æ˜¯ï¼Ÿ çŸ­æ—¥æ¤ç‰©çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o4shndshc/">
    
    
    
    
    
      
    
    å“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆçº¸ç‰‡æ‹åœ¨é¢å¤´ä¸Šç¡®å®æ®‹å¿µå•Šå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆå“ˆ<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@çŸ­æ—¥æ¤ç‰©<!-- raw HTML omitted -->:â€‚ä¹…ä¿è§‰å¾—å‘¨å¹´liveä¸Šæœ€å€’éœ‰çš„äº‹æ˜¯ï¼Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->çŸ­æ—¥æ¤ç‰©çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax4.sinaimg.c">https://tvax4.sinaimg.c</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O4SlbApLh">è½¬å‘å¾®åš - è½¬å‘ @å±±ä¸‹ç¾æœˆæ•™ä¼š:&amp;ensp;å±±ä¸‹ç¾æœˆ#å±±ä¸‹ç¾æœˆæ‰‹æœºåš# 240313.4è¿™ä¸ªæ˜¯åœ¨å‡é™å°æœ€é¡¶ç«¯çœ‹åˆ°çš„æ™¯è‰²å¯ä»¥çœ‹åˆ°ååœ¨ä¸Šé¢åº§ä½çš„ç²‰ä¸ä»¬å“¦åœ¨å‡é™å°ä¸Šè·³èˆä¼šæ‘‡æ™ƒ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o4slbaplh/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å±±ä¸‹ç¾æœˆæ•™ä¼š<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å±±ä¸‹ç¾æœˆ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O4SQBsnMA">è½¬å‘å¾®åš - è½¬å‘ @æ©‹æœ¬ç¿¼:&amp;ensp;å’Œæœˆç¼–ç»‡çš„åšå®ç¾ç»Šäº•ä¸Šå’Œ X è…åŸå’²æœˆ ************å’Œæœˆå…šå¿…çœ‹ å‰è¾¹ç¾æˆ˜çš„éƒ¨åˆ†å¯ä»¥è·³è¿‡ ç›´æ¥ä»ä¸­é—´ä¸¤äººå…³ç³»çš„éƒ¨åˆ†å¼€å§‹å…¨æ–‡ä»ä¸¤äºº...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o4sqbsnma/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@æ©‹æœ¬ç¿¼<!-- raw HTML omitted -->:â€‚å’Œæœˆç¼–ç»‡çš„åšå®ç¾ç»Š<!-- raw HTML omitted -->äº•ä¸Šå’Œ X è…åŸå’²æœˆ <!-- raw HTML omitted --><!-- raw HTML omitted --><strong><strong><strong><strong><strong><strong><!-- raw HTML omitted -->å’Œæœˆå…šå¿…çœ‹ <!-- raw HTML omitted -->å‰è¾¹ç¾æˆ˜çš„éƒ¨åˆ†å¯ä»¥è·³è¿‡ ç›´æ¥ä»ä¸­é—´ä¸¤äººå…³ç³»çš„éƒ¨åˆ†å¼€å§‹<!-- raw HTML omitted -->å…¨æ–‡ä»ä¸¤äººæœ€åˆçš„å½¼æ­¤å¸å¼• åˆ°å¤å·¡çš„æ¸è¡Œæ¸è¿œ<!-- raw HTML omitted -->åˆ°æœ€åæ–°å‚è€…çš„çœŸæƒ…æµéœ²<!-- raw HTML omitted -->æ»¡æ»¡çš„éƒ½æ˜¯å’Œæœˆçš„çˆ±ä¸çœŸå® <!-- raw HTML omitted --><!-- raw HTML omitted -->å…¨æ–‡ç¿»è¯‘ by å–µå–µé˜Ÿå­—å¹•ç»„<!-- raw HTML omitted --></strong></strong></strong></strong></strong></strong><!-- raw HTML omitted --><!-- raw HTML omitted -->æ­£æ–‡éƒ¨åˆ†<!-- raw HTML omitted --><!-- raw HTML omitted -->äº”æœŸç”Ÿç‰ˆã€Šç¾å°‘å¥³æˆ˜å£«ã€‹éŸ³ä¹å‰§ä¸­ï¼Œå°†æ‰®æ¼”æ°´å…µæœˆ/æœˆé‡å…”çš„ä¸¤ä½ã€‚â€œå’Œæœˆâ€å³å°†ç«æ¼”ä¹‹å‰ï¼Œå¬å¥¹ä»¬è®²è¿°å¯¹éŸ³ä¹å‰§çš„å¹²åŠ²ï¼Œä»¥åŠä»åŠ å…¥ä¹ƒæœ¨å‚46åˆ°ç°åœ¨äº’ç›¸æ”¯æŒä¸€è·¯èµ°æ¥çš„ç»å†ã€‚&lt; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O4T4XiHrr">å”‰ï¼Œåˆ°åº•ä¸ºä»€ä¹ˆä¸€å¤©åˆ°æ™šåœ¨äº’è”ç½‘ä¸Šæ‰¾éª‚ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o4t4xihrr/">
    
    
    
    
    
      
    
    å”‰ï¼Œåˆ°åº•ä¸ºä»€ä¹ˆä¸€å¤©åˆ°æ™šåœ¨äº’è”ç½‘ä¸Šæ‰¾éª‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5286768287/O4Tjvan7S">å•Šå•Šå•Šå•Šå•Šå•Šå•Šä¸æƒ³èµ·æ¥ç»™å¦¹å¦¹åšæ—©é¥­å•Šå•Šå•Šå•Šå•Š</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5286768287-o4tjvan7s/">
    
    
    
    
    
      
    
    å•Šå•Šå•Šå•Šå•Šå•Šå•Šä¸æƒ³èµ·æ¥ç»™å¦¹å¦¹åšæ—©é¥­å•Šå•Šå•Šå•Šå•Š  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O4M55Eexr">è½¬å‘å¾®åš - è½¬å‘ @å¤šæ¬¡å©‰æ‹’ä¹…ä¿ç»‡ç»‡:&amp;ensp;æ™•winkäº†ğŸ˜‡ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o4m55eexr/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@å¤šæ¬¡å©‰æ‹’ä¹…ä¿ç»‡ç»‡<!-- raw HTML omitted -->:â€‚æ™•winkäº†ğŸ˜‡ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O4N0Pbrmj">æ¬¡é€± ã€ã‚¤ãƒ¯ã‚¯ãƒ©ã¨å‰ä½ã®ç•ªçµ„ã€æœ‰ä¹ƒæœ¨å‚liveæ½›å…¥ç‰¹è¼¯ï¼ŒåŸä¾†çœŸç©ºå‚‘è¥¿å¡æ¡‘é‚„æ˜¯åœ¨æ¨ä¹…ä¿[å“ˆå“ˆ] [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o4n0pbrmj/">
    
    
    
    
    
      
    
    æ¬¡é€± ã€ã‚¤ãƒ¯ã‚¯ãƒ©ã¨å‰ä½ã®ç•ªçµ„ã€æœ‰ä¹ƒæœ¨å‚liveæ½›å…¥ç‰¹è¼¯ï¼ŒåŸä¾†çœŸç©ºå‚‘è¥¿å¡æ¡‘é‚„æ˜¯åœ¨æ¨ä¹…ä¿<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/005TCz76gy1hnp6e9wahvj30go09dwfh.jpg%22">https://tvax1.sinaimg.cn/large/005TCz76gy1hnp6e9wahvj30go09dwfh.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O4QC8eVs6">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.kashosanzen X [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o4qc8evs6/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.kashosanzen X &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy1hnpkv1oekcj312l0omafl.jpg%22">https://tvax4.sinaimg.cn/large/006z6nxLgy1hnpkv1oekcj312l0omafl.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O4Rz4vnU8">è½¬å‘å¾®åš - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.seventeen å®˜ç½‘ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o4rz4vnu8/">
    
    
    
    
    
      
    
    è½¬å‘å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.seventeen å®˜ç½‘ &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1hnpqgw5fuvj30ku0ogami.jpg%22">https://tvax3.sinaimg.cn/large/006z6nxLgy1hnpqgw5fuvj30ku0ogami.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O4S8Wr88Y">è¡£æœå¥½å¤§ï¼Œè‡‰å¥½å°ï¼ - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.ä¹ƒæœ¨å‚46 X [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o4s8wr88y/">
    
    
    
    
    
      
    
    è¡£æœå¥½å¤§ï¼Œè‡‰å¥½å°ï¼<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ä¹ƒæœ¨å‚46 X &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1hnps723m3pj31kw16oqc2">https://tvax2.sinaimg.cn/large/006z6nxLgy1hnps723m3pj31kw16oqc2</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/O4S9ejPJo">é‡çƒå¤ªéƒæ‰“éŒ¢[å“ˆå“ˆ] - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œvia.ä¹ƒæœ¨å‚46ann X [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-o4s9ejpjo/">
    
    
    
    
    
      
    
    é‡çƒå¤ªéƒæ‰“éŒ¢<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png%22">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default.png&quot;</a>  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O4N87tG2X">ä»Šå¹´æˆ‘åœ¨é‡ç‹çš„æŠ¼åˆ†æˆ˜ç»©æœ‰ç‚¹å´©ï¼Œå…¨éƒ¨æ¢­å“ˆçš„æƒ…å†µä¸‹ï¼Œä¸åˆ°2ä¸ªåŠæœˆå°±ç»å†äº†3æ¬¡å¤§å‹è¿è´¥ï¼š13è¿ã€13è¿ã€14è¿ã€‚è™½ç„¶å¤§éƒ¨åˆ†æ˜¯å·é¸¡ï¼Œä¸è¿‡è¿™ä¹ˆå¤§å‹è¿è´¥æˆ‘ä¹Ÿæ˜¯æœ‰ç‚¹æ²¡ç»·ä½è¿™...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o4n87tg2x/">
    
    
    
    
    
      
    
    ä»Šå¹´æˆ‘åœ¨é‡ç‹çš„æŠ¼åˆ†æˆ˜ç»©æœ‰ç‚¹å´©ï¼Œå…¨éƒ¨æ¢­å“ˆçš„æƒ…å†µä¸‹ï¼Œä¸åˆ°2ä¸ªåŠæœˆå°±ç»å†äº†3æ¬¡å¤§å‹è¿è´¥ï¼š13è¿ã€13è¿ã€14è¿ã€‚è™½ç„¶å¤§éƒ¨åˆ†æ˜¯å·é¸¡ï¼Œä¸è¿‡è¿™ä¹ˆå¤§å‹è¿è´¥æˆ‘ä¹Ÿæ˜¯æœ‰ç‚¹æ²¡ç»·ä½<!-- raw HTML omitted --><!-- raw HTML omitted -->è¿™ç§æƒ…å†µä¸‹è¿˜èƒ½æœ‰27%çš„å‡†ç¡®ç‡å·²ç»æ˜¯å¥‡è¿¹äº†  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O4PtZirdF">æ£‹æ‰‹æˆ˜é¹°cyç¤¾å¯èƒ½é€šä¸è¿‡ï¼Œæ®è¯´bç«™æœ‰æ±‰åŒ–ç‰ˆï¼Œè¦ä¸å¼•å…¥è¯•è¯•çœ‹ï¼Ÿ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o4ptzirdf/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æ£‹æ‰‹æˆ˜é¹°<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->cyç¤¾å¯èƒ½é€šä¸è¿‡ï¼Œæ®è¯´bç«™æœ‰æ±‰åŒ–ç‰ˆï¼Œè¦ä¸å¼•å…¥è¯•è¯•çœ‹ï¼Ÿ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5878312122/O4S8WzVrG">å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šä¸€åŠ›è¾½å¼ºåŠ¿å«å†•ï¼Œè¾¾æˆæ£‹åœ£ä¸‰è¿éœ¸ã€‹ #å›´æ£‹# å›´æ£‹ ä¸€åŠ›è¾½å¼ºåŠ¿å«å†•ï¼Œè¾¾æˆæ£‹åœ£ä¸‰è¿éœ¸ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5878312122-o4s8wzvrg/">
    
    
    
    
    
      
    
    å‘å¸ƒäº†å¤´æ¡æ–‡ç« ï¼šã€Šä¸€åŠ›è¾½å¼ºåŠ¿å«å†•ï¼Œè¾¾æˆæ£‹åœ£ä¸‰è¿éœ¸ã€‹ <!-- raw HTML omitted --><!-- raw HTML omitted -->#å›´æ£‹#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å›´æ£‹<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O4NPNn5ok">ä¹…ä¿å²ç»ªé‡Œvia. Seventeen ins [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o4npnn5ok/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->via. Seventeen ins <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1h">https://tvax3.sinaimg.cn/large/006z6nxLgy1h</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O4PWoy1ps">ä¹…ä¿å²ç»ªé‡Œã€Œä¹ƒæœ¨å‚46 ä¹…ä¿å²ç·’é‡Œã®å®®åŸãƒ»ä»™å° æ—…ã—ãŠã‚Šã€ä¼Šè±†æ²¼ãƒ»å†…æ²¼ ç¯‡ é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o4pwoy1ps/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->ã€Œä¹ƒæœ¨å‚46 ä¹…ä¿å²ç·’é‡Œã®å®®åŸãƒ»ä»™å° æ—…ã—ãŠã‚Šã€ä¼Šè±†æ²¼ãƒ»å†…æ²¼ ç¯‡ <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaim">https://h5.sinaim</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O4QI2bRd8">æ›´æ–°äº†ç¿»è¯‘[çˆ±ä½ ] - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œã€Œä¹ƒæœ¨å‚46 ä¹…ä¿å²ç·’é‡Œã®å®®åŸãƒ»ä»™å° æ—…ã—ãŠã‚Šã€ä¼Šè±†æ²¼ãƒ»å†…æ²¼ ç¯‡ é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o4qi2brd8/">
    
    
    
    
    
      
    
    æ›´æ–°äº†ç¿»è¯‘<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default">https://n.sinaimg.cn/photo/5213b46e/20180926/timeline_card_small_super_default</a>. &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O4Qiikcxw">ä¹…ä¿å²ç»ªé‡Œvia.kashosanzen X [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o4qiikcxw/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.kashosanzen X <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O4RWy8iO2">ä¹…ä¿å²ç»ªé‡Œvia.ä¹ƒæœ¨å‚46 X [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o4rwy8io2/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ä¹ƒæœ¨å‚46 X <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O4RxnuLOE">ä¹…ä¿å²ç»ªé‡Œvia.ç»ªè¡Œè®° ins [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o4rxnuloe/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ç»ªè¡Œè®° ins <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1hnpqeki3">https://tvax1.sinaimg.cn/large/006z6nxLgy1hnpqeki3</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O4Ryj8bkB">ä¹…ä¿å²ç»ªé‡Œvia.seventeen å®˜ç½‘ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o4ryj8bkb/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.seventeen å®˜ç½‘ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/006z6nxLgy1hnpqgw">https://tvax3.sinaimg.cn/large/006z6nxLgy1hnpqgw</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O4RZYzCu7">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# ç¨å25:00ï½ï¼ˆJSTï¼‰æ—¥æœ¬æ”¾é€ã€ä¹ƒæœ¨å‚46çš„ANNã€è¯·ä¸€å®šè¦å¬ï½ğŸ“» [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o4rzyzcu7/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/O4S4snFJe">ä¹…ä¿å²ç»ªé‡Œvia.ä¹ƒæœ¨å‚46ann X [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-03-13</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-o4s4snfje/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ä¹ƒæœ¨å‚46ann X <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

